+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 55647

Chapter 55647 contains a list of PDF Full Texts available from EurekaMag.

Wilkinson, C.P., 2011:
Safety of vitrectomy for floaters--how safe is safe?

Low, D.; Pettitt, J., 2012:
Safety of vulnerable children could be put at risk

Thomas, C.A.; Taylor, K.; Schamberger, M.S.; Rotta, A.T., 2015:
Safety of warfarin dosing in the intensive care unit following the Fontan procedure

Galipienzo, J.; García de Tena, J.; Flores, J.; Alvarez, Cón.; Alonso-Viteri, S.; Ruiz, A., 2010:
Safety of withholding anticoagulant therapy in patients with suspected pulmonary embolism with a negative multislice computed tomography pulmonary angiography

Tanimoto, T.; Uchida, N.; Kodama, Y.; Teshima, T.; Taniguchi, S., 2011:
Safety of workers at the Fukushima Daiichi nuclear power plant

Bradley, D., 2007:
Safety of young children in registered day care

Gaba, R.C.; Riaz, A.; Lewandowski, R.J.; Ibrahim, S.M.; Ryu, R.K.; Sato, K.T.; Omary, R.A.; Salem, R., 2010:
Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction

Twaites, B.R.; Wilton, L.V.; Shakir, S.A.W., 2007:
Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England

Coleman, R.; Woodward, E.; Brown, J.; Cameron, D.; Bell, R.; Dodwell, D.; Keane, M.; Gil, M.; Davies, C.; Burkinshaw, R.; Houston, S.J.; Grieve, R.J.; Barrett-Lee, P.J.; Thorpe, H., 2011:
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer

Tseng, H.F.; Liu, A.; Sy, L.; Marcy, S.M.; Fireman, B.; Weintraub, E.; Baggs, J.; Weinmann, S.; Baxter, R.; Nordin, J.; Daley, M.F.; Jackson, L.; Jacobsen, S.J., 2012:
Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study

Ibrahim, M.; Maselli, D.J.; Hasan, R., 2013:
Safety of β-blockers in the acute management of cocaine-associated chest pain

Erdmann, E., 2012:
Safety of β-blockers. Prejudices and reality

Bousquet, J.; Bourdin, A.; Demoly, P., 2014:
Safety of β2-agonists: a 50-year debate closed?

Nahata, M.C., 2009:
Safety of "inert" additives or excipients in paediatric medicines

Saumier, N.; Lorne, E.; Dermigny, F.; Walkzak, K.; Daelman, F.; Jezraoui, P.; Mahjoub, Y.; Milazzo, S.; Dupont, H., 2011:
Safety of "needle" regional anaesthesia for anterior segment surgery under antiplatelet agents and anticoagulants therapies

van de Meent, H.; Oerlemans, M.; Bruggeman, A.; Klomp, F.; van Dongen, R.; Oostendorp, R.; Frölke, J.Paul., 2011:
Safety of "pain exposure" physical therapy in patients with complex regional pain syndrome type 1

Ofori-Adjei, D., 2007:
Safety of "sachet water" and raw milk

Ogunsanya, T.J.; Durborow, R.M.; Myers, M.L.; Cole, H.P.; Thompson, S.L., 2011:
Safety on North Carolina and Kentucky trout farms

Shah, R.K.; Lander, L.; Forbes, P.; Jenkins, K.; Healy, G.B.; Roberson, D.W., 2009:
Safety on an inpatient pediatric otolaryngology service: many small errors, few adverse events

Okun, A., 2008:
Safety on bicycles, skateboards, scooters, and skates

Duffin, C., 2011:
Safety on board

Bilger, K., 2014:
Safety on ice

Foster, R.J.; Hotchkiss, J.; Buckley, J.G.; Elliott, D.B., 2015:
Safety on stairs: influence of a tread edge highlighter and its position

McGowan, D.R., 2014:
Safety on the streets

Kirkwood, S.; Myers, J.Brent., 2007:
Safety or marketing? Why we decorate our vehicles the way that we do

Vogus, T.J.; Cooil, B.; Sitterding, M.; Everett, L.Q., 2014:
Safety organizing, emotional exhaustion, and turnover in hospital nursing units

Greenberg, M.D.; Haviland, A.M.; Yu, H.; Farley, D.O., 2011:
Safety outcomes in the United States: trends and challenges in measurement

Sylaja, P.N.; Dong, W.; Grotta, J.C.; Miller, M.K.; Tomita, K.; Hamilton, S.; Semba, C.; Hill, M.D., 2007:
Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics

West, D., 2010:
Safety outcry is 'mandate' for quality

Faulkner, M.A., 2015:
Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson's disease

Wang, Y.Grace.; Swick, T.J.; Carter, L.P.; Thorpy, M.J.; Benowitz, N.L., 2010:
Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion

Stephenson, E.; Ogilvie, C.Mackie.; Patel, H.; Cornwell, G.; Jacquet, L.; Kadeva, N.; Braude, P.; Ilic, D., 2011:
Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells

Grisanti, S.; Altvater, A.; Peters, S., 2008:
Safety parameters for indocyanine green in vitreoretinal surgery

Casado Verdejo, Iés.; Postigo Mota, S.; Iglesias Guerra, Jé.Antonio.; Galán Andrés, M.Isabel.; Durán Gómez, N.; Muñoz Bermejo, L., 2011:
Safety patient in medication use and administration

Luria, G.; Yagil, D., 2010:
Safety perception referents of permanent and temporary employees: safety climate boundaries in the industrial workplace

Chen, H.; Zhou, H.; Zhao, J.; Hsu, P., 2011:
Safety performance evaluation of left-side off-ramps at freeway diverge areas

Venkataraman, N., 2008:
Safety performance factor

Barbosa, H.; Cunto, Fávio.; Bezerra, Bárbara.; Nodari, C.; Jacques, M.Alice., 2015:
Safety performance models for urban intersections in Brazil

Snyder, L.Anderson.; Krauss, A.D.; Chen, P.Y.; Finlinson, S.; Huang, Y-Hsiang., 2012:
Safety performance: the mediating role of safety control

Sazani, P.; Weller, D.L.; Shrewsbury, S.B., 2010:
Safety pharmacology and genotoxicity evaluation of AVI-4658

Himmel, H.M., 2008:
Safety pharmacology assessment of central nervous system function in juvenile and adult rats: effects of pharmacological reference compounds

Bass, A.S.; Vargas, H.M.; Valentin, J-Pierre.; Kinter, L.B.; Hammond, T.; Wallis, R.; Siegl, P.K.S.; Yamamoto, K., 2012:
Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society

Pugsley, M.K.; Dalton, J.A.; Authier, S.; Curtis, M.J., 2015:
Safety pharmacology in 2014: new focus on non-cardiac methods and models

Pihl, T.Holberg.; Jørgensen, C.Svaerke.; Santoni-Rugiu, E.; Leifsson, Páll.Skúli.; Hansen, E.Wind.; Laursen, I.; Houen, G., 2012:
Safety pharmacology, toxicology and pharmacokinetic assessment of human Gc globulin (vitamin D binding protein)

Hamdam, J.; Sethu, S.; Smith, T.; Alfirevic, A.; Alhaidari, M.; Atkinson, J.; Ayala, M.; Box, H.; Cross, M.; Delaunois, A.; Dermody, A.; Govindappa, K.; Guillon, J-Michel.; Jenkins, R.; Kenna, G.; Lemmer, Börn.; Meecham, K.; Olayanju, A.; Pestel, S.; Rothfuss, A.; Sidaway, J.; Sison-Young, R.; Smith, E.; Stebbings, R.; Tingle, Y.; Valentin, J-Pierre.; Williams, A.; Williams, D.; Park, K.; Goldring, C., 2014:
Safety pharmacology--current and emerging concepts

Dasgupta, K.S.; Lanjewar, K.Y.; Joshi, S.V., 2006:
Safety pin - The UNSAFE foreign body of air passage

Kuehn, B.M., 2010:
Safety plan for opioids meets resistance: opioid-linked deaths continue to soar

Hemingway, M.; Kilfoyle, M., 2014:
Safety planning for intraoperative magnetic resonance imaging

Mkandawire-Valhmu, L.; Stevens, P.E.; Kako, P.M.; Dressel, A., 2014:
Safety planning in focus groups of Malawian women living with HIV: helping each other deal with violence and abuse

Chanmugam, A.; Hall, K., 2013:
Safety planning with children and adolescents in domestic violence shelters

Coon, R., 2014:
Safety practices for county hospitals and institutions

Muragaki, Y.; Maruyama, T.; Tanaka, M.; Iseki, H.; Okada, Y., 2010:
Safety precaution of awake craniotomy

Brathwaite, D.; Aziz, F.; Eakins, C.; Charles, A.Jno.; Cristian, A., 2012:
Safety precautions in the rehabilitation medicine prescription

Sugino, M.; Todo, H.; Suzuki, T.; Nakada, K.; Tsuji, K.; Tokunaga, H.; Jinno, H.; Sugibayashi, K., 2014:
Safety prediction of topically exposed biocides using permeability coefficients and the desquamation rate at the stratum corneum

Saadat, S.; Naseripour, M.; Rahimi, B., 2009:
Safety preparedness of urban community for New Year fireworks in Tehran

Tutenges, Sébastien., 2009:
Safety problems among heavy-drinking youth at a Bulgarian nightlife resort

Yang, Y-Xia.; Yong, M-Chao., 2009:
Safety problems and countermeasures of electroacupuncture instruments

Fariña-López, E., 2011:
Safety problems associated with using physical restraint devices on the elderly

Pal'tsev, I.P.; Kravchenko, O.K.; Levina, A.V., 2008:
Safety problems of modern laser medical equipment

Jorquera, J.I., 2008:
Safety procedures of coagulation factors

Rossi, D.; Alessandroni, P.; Catalano, V.; Giordani, P.; Fedeli, S.Luzi.; Fedeli, A.; Baldelli, A.Maria.; Casadei, V.; Ceccolini, M.; Catalano, G., 2008:
Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer

May, C.H.; Lincoff, A.Michael., 2013:
Safety profile and bleeding risk of ticagrelor compared with clopidogrel

Zhou, Q.; Dergunov, S.A.; Zhang, Y.; Li, X.; Mu, Q.; Zhang, Q.; Jiang, G.; Pinkhassik, E.; Yan, B., 2011:
Safety profile and cellular uptake of biotemplated nanocapsules with nanometre-thin walls

Parker, J.M.; Oh, C.K.; LaForce, C.; Miller, S.David.; Pearlman, D.S.; Le, C.; Robbie, G.J.; White, W.I.; White, B.; Molfino, N.A.; Boulet, L-Philippe.; Fogarty, C.; Gauvreau, G.; Kaiser, H.; Lemiere, C.; Brazinsky, S.; Nayak, A.; Korenblat, P., 2011:
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

Merrill, J.T.; Wallace, D.J.; Petri, M.; Kirou, K.A.; Yao, Y.; White, W.I.; Robbie, G.; Levin, R.; Berney, S.M.; Chindalore, V.; Olsen, N.; Richman, L.; Le, C.; Jallal, B.; White, B., 2011:
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

Adkins, D.; Ratanatharathorn, V.; Yang, H.; White, B., 2009:
Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease

Ateba, S.Benjamin.; Simo, R.Valdès.; Mbanya, J.Claude.; Krenn, L.; Njamen, Dé., 2014:
Safety profile and gender specific differences of a methanol extract of Eriosema laurentii (Leguminosae) in acute and subchronic (28 days) oral toxicity studies in Wistar rats

Ribas, A.; Chesney, J.A.; Gordon, M.S.; Abernethy, A.P.; Logan, T.F.; Lawson, D.H.; Chmielowksi, B.; Glaspy, J.A.; Lewis, K.; Huang, B.; Wang, E.; Hsyu, P-Hirr.; Gomez-Navarro, J.; Gerhardt, D.; Marshall, M.A.; Gonzalez, R., 2013:
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

Rossi, C.; Reginelli, A.; D'Amora, M.; Di Grezia, G.; Mandato, Y.; D'Andrea, A.; Brunese, L.; Grassi, R.; Rotondi, A., 2014:
Safety profile and protocol prevention of adverse reactions to uroangiographic contrast media in diagnostic imaging

Gadgeel, S.M., 2012:
Safety profile and tolerability of antiangiogenic agents in non-small-cell lung cancer

Verzoni, E.; Pusceddu, S.; Buzzoni, R.; Garanzini, E.; Damato, A.; Biondani, P.; Testa, I.; Grassi, P.; Bajetta, E.; de Braud, F.; DeBraud, F.; Procopio, G., 2015:
Safety profile and treatment response of everolimus in different solid tumors: an observational study

Bucolo, C.; Longo, L.; Camillieri, G.; Drago, F.; Salomone, S., 2013:
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011

Vatlach, S.; Arand, J.; Engel, C.; Poets, C.F., 2014:
Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity

Thome, J.; Doppler, E., 2012:
Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials

Falade, C.; Manyando, C., 2010:
Safety profile of Coartem: the evidence base

Bigliardi, S.; Morselli, M.; Potenza, L.; Coluccio, V.; Maccaferri, M.; Paolini, A.; Colaci, E.; Fantuzzi, V.; Faglioni, L.; Soci, F.; Nasillo, V.; Messerotti, A.; Pedrazzi, P.; Marietta, M.; Luppi, M.; Forghieri, F., 2016:
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study

Lalezari, J.; Latiff, G.H.; Brinson, C.; Echevarria, J.; Treviño-Pérez, S.; Bogner, J.R.; Stock, D.; Joshi, S.R.; Hanna, G.J.; Lataillade, M., 2014:
Safety profile of HIV-1 attachment inhibitor prodrug BMS-663068 in antiretroviral-experienced subjects: week 24 analysis

Dent, M.P.; Wolterbeek, A.P.M.; Russell, P.J.; Bradford, R., 2012:
Safety profile of Hoodia gordonii extract: mouse prenatal developmental toxicity study

Dent, M.P.; Wolterbeek, A.P.M.; Russell, P.J.; Bradford, R., 2012:
Safety profile of Hoodia gordonii extract: rabbit prenatal developmental toxicity study

Afif, W.; Loftus, E.V., 2009:
Safety profile of IBD therapeutics: infectious risks

Bewtra, M.; Lewis, J.D., 2010:
Safety profile of IBD: lymphoma risks

Yeo, T.W.; Lampah, D.A.; Gitawati, R.; Tjitra, E.; Kenangalem, E.; Granger, D.L.; Weinberg, J.Brice.; Lopansri, B.K.; Price, R.N.; Celermajer, D.S.; Duffull, S.B.; Anstey, N.M., 2008:
Safety profile of L-arginine infusion in moderately severe falciparum malaria

Young, S.H.Y.; Zhao, Y.; Koh, A.; Singh, R.; Chan, B.P.L.; Chang, H.Meng.; Venketasubramanian, N.; Chen, C.; Young, S.H.Y.; Chan, B.P.L.; Sharma, V.Kumar.; Teoh, H.Luen.; Seet, R.; Venketasubramanian, N.; Chang, H.Meng.; de Silva, D.; Singh, R., 2010:
Safety profile of MLC601 (Neuroaid) in acute ischemic stroke patients: A Singaporean substudy of the Chinese medicine neuroaid efficacy on stroke recovery study

Swain, S.M.; Im, Y-Hyuck.; Im, S-Ah.; Chan, V.; Miles, D.; Knott, A.; Clark, E.; Ross, G.; Baselga, Jé., 2015:
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA

Barros, S.A.; Gollob, J.A., 2013:
Safety profile of RNAi nanomedicines

Iaffaldano, P.; D'Onghia, M.; Trojano, M., 2010:
Safety profile of Tysabri: international risk management plan

Song, H.; Shi, H.; Zhang, X.; Wang, J.; Yu, Y.; Chen, W.; Zhou, H., 2015:
Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment

Khraishi, M.; Russell, A.; Olszynski, W.P., 2011:
Safety profile of abatacept in rheumatoid arthritis: a review

Trivedi, D.; Denniston, A.K.O.; Murray, P.I., 2012:
Safety profile of anterior chamber paracentesis performed at the slit lamp

Stamp, L.K., 2014:
Safety profile of anti-gout agents: an update

Hori, S., 2012:
Safety profile of antimicrobial agents

Barańska-Rybak, W.; Pikula, Mł.; Dawgul, Młgorzata.; Kamysz, W.; Trzonkowski, P.; Roszkiewicz, J., 2013:
Safety profile of antimicrobial peptides: camel, citropin, protegrin, temporin a and lipopeptide on HaCaT keratinocytes

Plourde, P.V.; Jeha, S.; Hijiya, N.; Keller, F.G.; Silverman, L.B.; Rheingold, S.R.; Dreyer, Z.E.; Dahl, G.V.; Mercedes, T.; Lai, C.; Corn, T., 2014:
Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial

Yoeruek, E.; Spitzer, M.S.; Tatar, O.; Aisenbrey, S.; Bartz-Schmidt, K.U.; Szurman, P., 2007:
Safety profile of bevacizumab on cultured human corneal cells

Scaglione, F., 2013:
Safety profile of bilastine: 2nd generation H1-antihistamines

Cole, B.J.; Provencher, M.T., 2007:
Safety profile of bioabsorbable shoulder anchors

Corominas, Hèctor.; Sánchez-Eslava, L.; García, G.; Padró, I.; Aimarich, C.; Gonzàlez, J.; Franco, M.; Mur, E.; Sanchez, S.; Roldán, Gòria.; Iniesta, S.; Sesma, M.; Martín, J.; Rodriguez, M.Carmen.; Capellan, M.Rosa.; Gosálvez, C.; Garcia-Diaz, S.; Sáez, Eón.; Luna, Y.; Plana, P., 2013:
Safety profile of biological intravenous therapy in a rheumatoid arthritis patients cohort. Clinical nursing monitoring (Sebiol study)

Cutroneo, P.M.; Isgrò, V.; Russo, A.; Ientile, V.; Sottosanti, L.; Pimpinella, G.; Conforti, A.; Moretti, U.; Caputi, A.P.; Trifirò, G., 2015:
Safety profile of biological medicines as compared with non-biologicals: an analysis of the italian spontaneous reporting system database

Gordon, S.C.; Muir, A.J.; Lim, J.K.; Pearlman, B.; Argo, C.K.; Ramani, A.; Maliakkal, B.; Alam, I.; Stewart, T.G.; Vainorius, M.; Peter, J.; Nelson, D.R.; Fried, M.W.; Reddy, K.Rajender., 2015:
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET

Sabel, M.; Giese, A., 2008:
Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

Granizo, J.J.; Aguilar, L.; Gimenez, M.J.; Coronel, P.; Gimeno, M.; Prieto, J., 2009:
Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections

Ptaszynska, A.; Johnsson, K.M.; Parikh, S.J.; de Bruin, T.W.A.; Apanovitch, A.Marie.; List, J.F., 2015:
Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events

Peura, D.A.; Metz, D.C.; Dabholkar, A.H.; Paris, M.M.; Yu, P.; Atkinson, S.N., 2010:
Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience

Yeo, W.Wai.Yeng.; Hosseinkhani, H.; Rahman, S.A.; Rosli, R.; Domb, A.J.; Abdullah, S., 2014:
Safety profile of dextran-spermine gene delivery vector in mouse lungs

Varenna, M.; Bertoldo, F.; Di Monaco, M.; Giusti, A.; Martini, G.; Rossini, M., 2014:
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

Caillet, Céline.; Chauvelot-Moachon, L.; Montastruc, J-Louis.; Bagheri, H., 2013:
Safety profile of enantiomers vs. racemic mixtures: it's the same?

Petrov, I.; Grozdinski, L.; Kaninski, G.; Iliev, N.; Iloska, M.; Radev, A., 2011:
Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis

Gridelli, C.; Maione, P.; Galetta, D.; Rossi, A., 2007:
Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure

Davies, M.; Wilton, L.V.; Shakir, S.A.W., 2008:
Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England

Anderson, T.J.; Boden, W.E.; Desvigne-Nickens, P.; Fleg, J.L.; Kashyap, M.L.; McBride, R.; Probstfield, J.L., 2014:
Safety profile of extended-release niacin in the AIM-HIGH trial

Akhtar, M.Irfan.; Hamid, M.; Minai, F.; Wali, A.Rehmat.; Anwar-Ul-Haq; Aman-Ullah, M.; Ahsan, K., 2014:
Safety profile of fast-track extubation in pediatric congenital heart disease surgery patients in a tertiary care hospital of a developing country: An observational prospective study

Muhammad, A.K.M.Ghulam.; Xiong, W.; Puntel, M.; Farrokhi, C.; Kroeger, K.M.; Salem, A.; Lacayo, L.; Pechnick, R.N.; Kelson, K.R.; Palmer, D.; Ng, P.; Liu, C.; Lowenstein, P.R.; Castro, M.G., 2013:
Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial

Manocha, D.; Bansal, N.; Gumaste, P.; Brangman, S., 2014:
Safety profile of high-dose statin therapy in geriatric patients with stroke

Gatzioufas, Z.; Richoz, O.; Brugnoli, E.; Hafezi, F., 2014:
Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study

Spoerl, D.; Bircher, A.J.; Scherer, K., 2011:
Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom

Dargani, N.V.; Malhotra, A.K., 2014:
Safety profile of iloperidone in the treatment of schizophrenia

Langley, R.G.; Papp, K.; Bissonnette, R.; Toth, D.; Matheson, R.; Hultquist, M.; White, B., 2010:
Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies

Sousa, A.Maria.; de Santana Neto, Jé.; Guimaraes, G.M.N.; Cascudo, G.M.; Neto, Jé.Osvaldo.B.; Ashmawi, H.A., 2014:
Safety profile of intravenous patient-controlled analgesia for breakthrough pain in cancer patients: a case series study

Goulleret, N.; Mauvisseau, E.; Essevaz-Roulet, Mélanie.; Quinlivan, M.; Breuer, J., 2010:
Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP)

Kramer, K.; Smith, M.; Souweidane, M.M., 2014:
Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies

Lazzarin, A.; Than, S.; Valluri, S.R.; Heera, J.; Mukwaya, G., 2012:
Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program

Linden, P., 2007:
Safety profile of meropenem: an updated review of over 6,000 patients treated with meropenem

Davies, M.; Wilton, L.; Shakir, S., 2013:
Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study

Kolaski, K.; Ajizian, S.J.; Passmore, L.; Pasutharnchat, N.; Koman, L.Andrew.; Smith, B.P., 2008:
Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population

Mansi, L.; Thiery-Vuillemin, A.; Nguyen, T.; Bazan, F.; Calcagno, F.; Rocquain, J.; Demarchi, M.; Villanueva, C.; Maurina, T.; Pivot, X., 2010:
Safety profile of new anticancer drugs

Donner, B.; Bader-Weder, S.; Schwarz, R.; Peng, M.M.; Smith, J.Robert.; Niranjan, V., 2011:
Safety profile of oseltamivir during the 2009 influenza pandemic

Buggy, Y.; Layton, D.; Fogg, C.; Shakir, S.A.W., 2010:
Safety profile of oxcarbazepine: results from a prescription-event monitoring study

Skalova, S.; Rejtar, P., 2011:
Safety profile of paediatric percutaneous ultrasonography-guided renal biopsies

Rheims, S., 2012:
Safety profile of phenobarbital: can meta-analyses tell us the truth?

Wirth, T.; Hedman, M.; Mäkinen, K.; Manninen, H.; Immonen, A.; Vapalahti, M.; Ylä-Herttuala, S., 2008:
Safety profile of plasmid/liposomes and virus vectors in clinical gene therapy

Destefano, F.; Pfeifer, D.; Nohynek, H., 2008:
Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data

Gupta, A.; Kekunnaya, R.; Ramappa, M.; Vaddavalli, P.K., 2011:
Safety profile of primary intraocular lens implantation in children below 2 years of age

Salgado, E.; Maneiro, J.R.; Carmona, L.; Gomez-Reino, J.J., 2014:
Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis

Salmon, F.; Grosios, K.; Petry, H., 2014 :
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®)

López Cortés, L.F.; Martínez, E.; von Wichmann, M.Ángel., 2015:
Safety profile of rilpivirine: general and neuropsychiatric tolerability, safety in patients with hepatitis B or C viruses, and lipid profile

Agarwal, P.K.; Sammon, J.; Bhandari, A.; Dabaja, A.; Diaz, M.; Dusik-Fenton, S.; Satyanarayana, R.; Simone, A.; Trinh, Q-Dien.; Baize, B.; Menon, M., 2011:
Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients

Henley, D.B.; Sundell, K.L.; Sethuraman, G.; Dowsett, S.A.; May, P.C., 2015:
Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings

Malagari, K.; Pomoni, M.; Spyridopoulos, T.N.; Moschouris, H.; Kelekis, A.; Dourakis, S.; Alexopoulou, E.; Koskinas, J.; Angelopoulos, M.; Kornezos, J.; Pomoni, A.; Tandeles, S.; Marinis, A.; Rizos, S.; Kelekis, D., 2011:
Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients

Eren, M.; Yıldırım, S.Hekim.; Sivrikoz, I.Ak., 2011:
Safety profile of six months lansoprozole treatment in children

Marcellin, P.; Roberts, S.K.; Reddy, K.Rajender.; Harrison, S.A.; Jensen, D.M.; Hadziyannis, S.; Diago, M.; Weltman, M.; Messinger, D.; Tatsch, F.; Rizzetto, M., 2013:
Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

Toth, P.P.; Morrone, D.; Weintraub, W.S.; Hanson, M.E.; Lowe, R.S.; Lin, J.; Shah, A.K.; Tershakovec, A.M., 2012:
Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks

Ellapparadja, P.; Husami, Y.; McLeod, I., 2014:
Safety profile of sural nerve in posterolateral approach to the ankle joint: MRI study

Akimoto, K.; Kusunoki, Y.; Nishio, S.; Takagi, K.; Kawai, S., 2008:
Safety profile of tacrolimus in patients with rheumatoid arthritis

Schuller, E.; Klingler, A.; Dubischar-Kastner, K.; Dewasthaly, S.; Müller, Z., 2012:
Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®)

Lapi, F.; Tuccori, M.; Motola, D.; Pugi, A.; Vietri, M.; Montanaro, N.; Vaccheri, A.; Leoni, O.; Cocci, A.; Leone, R.; Conforti, A.; Moretti, U.; Sessa, E.; Mazzaglia, G.; Mugelli, A.; Mazzei, T.; Vannacci, A., 2010:
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy

Liu, H.H., 2010:
Safety profile of the fluoroquinolones: focus on levofloxacin

Van Bambeke, Fçoise.; Tulkens, P.M., 2009:
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes

Cottin, P.; Niedrig, M.; Domingo, C., 2014:
Safety profile of the yellow fever vaccine Stamaril®: a 17-year review

Leizorovicz, A.; Siguret, V.; Mottier, D.; Leizorovicz, A.; Siguret, V.; Mottier, D.; Clonier, F.; Janas, M.; Stinson, J.; Townshend, G.; Maddalena, M.; Leizorovicz, A.; Siguret, V.; Mottier, D.; Bauersachs, R.; Ribera Casado, Jé-Manuel.; Maksimovic, Z.; Gutowski, P.; Fiessinger, J.Noël.; Girard, P.; Parent, F.; Boddaert, J.; Bost, V.; Steg, G.; Baumelou, A.; Bounameaux, H.; Torres, F.; Matthes, B.Kemkes.; Tørnqvist, K.; Pedersen, T.Fischer.; Rasmussen, I.; Clonier, F.; Janas, M.; Stinson, J., 2011:
Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: the Innohep® in Renal Insufficiency Study (IRIS)

Bock, F.; Onderka, J.; Rummelt, C.; Dietrich, T.; Bachmann, Börn.; Kruse, F.E.; Schlötzer-Schrehardt, U.; Cursiefen, C., 2009 :
Safety profile of topical VEGF neutralization at the cornea

Taylor, R.S.; Fotopoulos, G.; Maibach, H., 2011:
Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions

González Martín, A., 2011:
Safety profile of trabectedin in combination with liposomal pegylated doxorrubicin in relapsed ovarian carcinoma: considerations for optimal management

Lapchak, P.A.; Han, M-Ku.; Salgado, K.F.; Streeter, J.; Zivin, J.A., 2008:
Safety profile of transcranial near-infrared laser therapy administered in combination with thrombolytic therapy to embolized rabbits

Robinson-Papp, J.; Simpson, D.M., 2007:
Safety profile of treatment in diabetic peripheral neuropathic pain

Passerotti, C.C.; Begg, N.; Penna, F.J.; Passerotti, A.Maria.A.M.S.; Leite, K.R.M.; Antunes, A.Azoubel.; Srougi, M.; Retik, A.B.; Nguyen, H.T., 2009:
Safety profile of trocar and insufflation needle access systems in laparoscopic surgery

Faulkner, M.A.; Burke, R.A., 2014:
Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel

Thurston, T.E.; Andrades, P.; Phillips, R.A.; Ray, P.D.; Grant, J.H., 2009:
Safety profile of wire osteosynthesis in craniosynostosis surgery

Goni, V.G.; Chhabra, R.; Gupta, A.; Marwaha, N.; Dhillon, M.S.; Pebam, S.; Gopinathan, N.Raj.; Bangalore Kantharajanna, S., 2014:
Safety profile, feasibility and early clinical outcome of cotransplantation of olfactory mucosa and bone marrow stem cells in chronic spinal cord injury patients

Busse, W.W.; Katial, R.; Gossage, D.; Sari, S.; Wang, B.; Kolbeck, R.; Coyle, A.J.; Koike, M.; Spitalny, G.L.; Kiener, P.A.; Geba, G.P.; Molfino, N.A., 2010:
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma

Pruett, T.L.; McGory, R.W.; Wright, F.H.; Pescovitz, M.D.; Yang, H.; McClain, J.B., 2010:
Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipients

Jung, S-Jung.; Kasala, D.; Choi, J-Woo.; Lee, S-Hwan.; Hwang, J.Kyu.; Kim, S.Wan.; Yun, C-Ok., 2015:
Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model

Mendes, D.; Alves, C.; Batel-Marques, F., 2015:
Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events

Malik, D.; Tarek, M.; Caceres del Carpio, J.; Ramirez, C.; Boyer, D.; Kenney, M.Cristina.; Kuppermann, B.D., 2014:
Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture

Yamamoto, Y.; Iwase, H., 2008:
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer

Fuloria, J., 2012:
Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer

Hotta, K.; Kiura, K., 2012:
Safety profiles of erlotinib therapy in patients with advanced non-small-cell lung cancer

Ishii, M.; Nagaoka, S.; Tatsumi, M.; Kitagawa, N.; Taketsuna, M.; Okubo, S.; Maeda, K.; Takeuchi, K., 2012:
Safety profiles of gemcitabine hydrochloride(GEMZAR®)in Japanese clinical studies

Tinsley, S.M., 2010:
Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

Perez, E.A., 2007:
Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer

Hassanein, A.A.G.; Hanna, R.S., 2007:
Safety programmes in the Egyptian construction industry

Schorr, J.P.; Hamdar, S.H., 2015:
Safety propensity index for signalized and unsignalized intersections: exploration and assessment

Dick, T., 2008:
Safety questions. Are you providing what your crews need to stay safe?

Kingman, M.S.; Chin, K., 2014:
Safety recommendations for administering intravenous prostacyclins in the hospital

Hirayama, Y., 2010:
Safety regulation for medicines and foodstuffs

Cho, W-Kap., 2009:
Safety regulation for the design approval of special form radioactive sources

Hamada, N.; Ogino, H.; Fujimichi, Y., 2013:
Safety regulations of food and water implemented in the first year following the Fukushima nuclear accident

Chenot, J-François.; Hua, T.Duc.; Abu Abed, M.; Schneider-Rudt, H.; Friede, T.; Schneider, S.; Vormfelde, S.Viktor., 2015:
Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care

McLaughlin, S., 2007:
Safety report. Update from the NFPA annual conference

Rajadhyaksha, V., 2012:
Safety reporting - Making it safely effective or effectively safe?

Watanabe, N.; Omori, I.M.; Nakagawa, A.; Cipriani, A.; Barbui, C.; McGuire, H.; Churchill, R.; Furukawa, T.A., 2010:
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis

Yazici, Y., 2009:
Safety reporting in randomized clinical trials - a need for improvement

Pak, J.; Chang, J-Jin.; Lee, J.Hun.; Lee, S.Hee., 2014:
Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints

Mascherek, A.; Kobler, I.; Bezzola, P., 2014:
Safety requires good communication

Ternov, S., 2009:
Safety requires hard work and harsh imposition from the authorities

Tong, Y.; Yang, J.; Li, C.; He, W., 2012:
Safety research in Chinese medicines based on application of data mining

Aitken, M.E.; Bowman, S.M.; Card-Higginson, P.; Carson, J.E.; Lin, T.Mei.; Thompson, J.W.; Zhao, Y., 2008:
Safety restraint use linked to hospital use and charges in Arkansas

Konstantinova, M.; Loizeau, V.; Pilorget, V.; Cali, A.; Danne, T., 2015:
Safety results from OCAPI: a European Observational Cohort Study of insulin glulisine-treated children aged 6-12 years with type 1 diabetes

Farnier, M., 2011:
Safety review of combination drugs for hyperlipidemia

Ludlam, W.H.; Anthony, L., 2012:
Safety review: dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors

Montana, M.; Verhaeghe, P.; Ducros, C.; Terme, T.; Vanelle, P.; Rathelot, P., 2013:
Safety review: squalene and thimerosal in vaccines

Woratanarat, P.; Ingsathit, A.; Chatchaipan, P.; Suriyawongpaisal, P., 2014:
Safety riding program and motorcycle-related injuries in Thailand

López-Arquillos, A.; Rubio-Romero, J.Carlos.; Gibb, A.G.F.; Gambatese, J.A., 2016:
Safety risk assessment for vertical concrete formwork activities in civil engineering construction

Aminbakhsh, S.; Gunduz, M.; Sonmez, R., 2014:
Safety risk assessment using analytic hierarchy process (AHP) during planning and budgeting of construction projects

Jenke, D., 2015:
Safety risk categorization of organic extractables associated with polymers used in packaging, delivery and manufacturing systems for parenteral drug products

Romano, M., 2007:
Safety risk? Members seek info on residents' hours

Morales, D.R.; Lipworth, B.J.; Guthrie, B.; Jackson, C.; Donnan, P.T.; Santiago, V.H., 2014:
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials

Herman, R.A.; Song, P.; Zhuang, M., 2012:
Safety risks of cryptic reading frames and gene disruption due to crop transgenesis: what are the odds?

Anonymous, 2013:
Safety risks of electronic health records

Marzella, L.; Blank, M.; Gelperin, K.; Johann-Liang, R., 2007:
Safety risks with gadolinium-based contrast agents

Dressler, R.; Consiglio-Ward, L.; Moore, C.; Savoy, M.; Aboff, B.; Salam, T.; Jordan, J.; Collier, V.U., 2014:
Safety science as second nature: training residents to use best practices instinctively to keep patients safe

Wagner, D.P.; Sparks, H.V.; Fink, G., 2011:
Safety science meets basic science in problem-based learning

Kawasaki, Y.; Hirano, T.; Miyatake, K.; Fujii, K.; Takeda, Y., 2014:
Safety screw fixation technique in a case of coracoid base fracture with acromioclavicular dislocation and coracoid base cross-sectional size data from a computed axial tomography study

Toriizuka, K.; Tsutani, K., 2008:
Safety securing and safety monitoring of herbal medicines, finished herbal products and supplements

Katz-Navon, T.; Naveh, E.; Stern, Z., 2007:
Safety self-efficacy and safety performance: potential antecedents and the moderation effect of standardization

Swift, L., 2010:
Safety sets sail in San Diego

Pontes, H.; Clément, M.; Rollason, V., 2015:
Safety signal detection: the relevance of literature review

Fernando, A.B.P.; Urcelay, G.P.; Mar, A.C.; Dickinson, A.; Robbins, T.W., 2015:
Safety signals as instrumental reinforcers during free-operant avoidance

Genud-Gabai, R.; Klavir, O.; Paz, R., 2014:
Safety signals in the primate amygdala

Christianson, J.P.; Jennings, J.H.; Ragole, T.; Flyer, J.G.N.; Benison, A.M.; Barth, D.S.; Watkins, L.R.; Maier, S.F., 2011:
Safety signals mitigate the consequences of uncontrollable stress via a circuit involving the sensory insular cortex and bed nucleus of the stria terminalis

Calda, P., 2009:
Safety signals of 17-OHP-C use in pregnancy and efficacy in the prevention of preterm birth

Macpherson, A.K.; Jones, J.; Rothman, L.; Macarthur, C.; Howard, A.W., 2011:
Safety standards and socioeconomic disparities in school playground injuries: a retrospective cohort study

Levin, S.A., 1988:
Safety standards for the environmental release of genetically engineered organisms

Waldman, S.V.; Grancelli, H.; Yaman, B.; Cohen Arazi, H., 2011:
Safety standards for the use of magnetic resonance in patients with cardiovascular devices

Bier, D.M., 2012:
Safety standards in infant nutrition: a United States perspective

Cole, H.P.; Piercy, L.R.; Heinz, K.L.; Westneat, S.C.; Arrowsmith, H.E.; Raymond, K.M., 2009 :
Safety status of farm tractors that operate on public highways in four rural Kentucky counties

Guédon, A.C.P.; Wauben, L.S.G.L.; Overvelde, M.; Blok, J.H.; van der Elst, M.; Dankelman, J.; van den Dobbelsteen, J.J., 2015:
Safety status system for operating room devices

Shokida, M.Felisa.; Gabriel, J.; Sanchez, C., 2008:
Safety stitch: a modification to postoperatively adjustable suture strabismus surgery of the inferior rectus muscle

Terezakis, S.A.; Pronovost, P.; Harris, K.; Deweese, T.; Ford, E., 2011:
Safety strategies in an academic radiation oncology department and recommendations for action

Galloway, S.M., 2014:
Safety strategy: what great leaders do well

Williams, L.D.; Burdock, G.A.; Shin, E.; Kim, S.; Jo, T.H.; Jones, K.N.; Matulka, R.A., 2010:
Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix

Williams, L.D.; Burdock, G.A.; Edwards, J.A.; Beck, M.; Bausch, J., 2009:
Safety studies conducted on high-purity trans-resveratrol in experimental animals

Mburu, N.; Obiero, J.A.; Waititu, K.; Mwaura, B.N.; Orawo, J.O.; Farah, I.O.; Mwethera, P.G., 2010:
Safety studies of a recently developed microbicidal contraceptive gel (UniPron) in female baboons (Papio anubis)

Abe, Y., 2011:
Safety studies of nanomaterials about intracellular distribution and genotoxicity

Traul, K.A.; Romero, J.B.; Brayton, C.; DeTolla, L.; Forbes-McBean, N.; Halquist, M.S.; Karnes, H.Thomas.; Sarabia-Estrada, R.; Tomlinson, M.J.; Tyler, B.M.; Ye, X.; Zadnik, P.; Guarnieri, M., 2015:
Safety studies of post-surgical buprenorphine therapy for mice

Kaur, S.; Prabha, V.; Kaur, K., 2012:
Safety studies of sperm agglutinating factor produced by Staphylococcus aureus as a vaginal contraceptive: in vivo studies

Knowles, M.Kimberly.; Nadin-Davis, S.A.; Sheen, M.; Rosatte, R.; Mueller, R.; Beresford, A., 2009:
Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species

Jenks, N.; Myers, R.; Greiner, S.M.; Thompson, J.; Mader, E.K.; Greenslade, A.; Griesmann, G.E.; Federspiel, M.J.; Rakela, J.; Borad, M.J.; Vile, R.G.; Barber, G.N.; Meier, T.R.; Blanco, M.C.; Carlson, S.K.; Russell, S.J.; Peng, K-Whye., 2010:
Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates

LeBlanc, A.K.; Naik, S.; Galyon, G.D.; Jenks, N.; Steele, M.; Peng, K-Whye.; Federspiel, M.J.; Donnell, R.; Russell, S.J., 2014:
Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs

Heimbach, J.T.; Marone, P.A.; Hunter, J.M.; Nemzer, B.V.; Stanley, S.M.; Kennepohl, E., 2010:
Safety studies on products from whole coffee fruit

Hasler, P.W.; Bloch, S.Brandi.; Villumsen, Jørgen.; Fuchs, J.; Lund-Andersen, H.; Larsen, M., 2015:
Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting

Benninger, D.H.; Lomarev, M.; Wassermann, E.M.; Lopez, G.; Houdayer, E.; Fasano, R.E.; Dang, N.; Hallett, M., 2009:
Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease

Li, W-juan.; Dai, Y.; Han, Y.; Qiu, Z-feng.; Xie, J.; Zuo, L-yan.; Li, Y-ling.; Li, T-sheng., 2012:
Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients

Salegio, E.A.; Samaranch, L.; Jenkins, R.W.; Clarke, C.J.; Lamarre, C.; Beyer, J.; Kells, A.P.; Bringas, J.; Sebastian, W.San.; Richardson, R.Mark.; Rosenbluth, K.H.; Hannun, Y.A.; Bankiewicz, K.S.; Forsayeth, J., 2013:
Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain

Dover, S.E.; Aroutcheva, A.A.; Faro, S.; Chikindas, M.L., 2008:
Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus

Wilkie, D.A.; Stone Hoy, S.; Gemensky-Metzler, A.; Colitz, C.M.H., 2016:
Safety study of capsular tension ring use in canine phacoemulsification and IOL implantation

Motoi, M.; Ohno, N., 2012:
Safety study of culinary-medicinal Royal Sun Agaricus, Agaricus brasiliensis S. Wasser et al. KA21 (higher Basidiomycetes) assessed by prokaryotic as well as eukaryotic systems

Mao, Z-Hai.; Jin, J.; Li, J-Wen.; Deng, Y-Xin.; Wang, M-Liang.; Lu, A-Guo.; Hu, W-Guo.; Zheng, M-Hua., 2010:
Safety study of laparoscopic surgery for colorectal cancer in elderly patients

Ley, M.; Vivanco, R.; Massot, A.; Jiménez, J.; Roquer, J.; Rocamora, R., 2015:
Safety study of long-term video-electroencephalogram monitoring

Higashihara, E.; Nutahara, K.; Okegawa, T.; Tanbo, M.; Mori, H.; Miyazaki, I.; Nitatori, T.; Kobayashi, K., 2016:
Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan

Chan, N.P.Y.; Shek, S.Y.N.; Yu, C.S.; Ho, S.G.Y.; Yeung, C.K.; Chan, H.H.L., 2012:
Safety study of transcutaneous focused ultrasound for non-invasive skin tightening in Asians

Sirriyeh, R.; Lawton, R.; Armitage, G.; Gardner, P.; Ferguson, S., 2012:
Safety subcultures in health-care organizations and managing medical error

Anonymous, 2013:
Safety summary: Computed tomography

Anonymous, 2013:
Safety summary: Defibrillators

Anonymous, 2013:
Safety summary: Patient lifts

Anonymous, 2013:
Safety summary: ventilators

Pater, R., 2014:
Safety super vision

Izumi, T., 2007:
Safety support for medical device: 2. Concrete contents of revision and points to be considered

Izumi, T., 2007:
Safety support for medical device: 3. Business: what we should do for control

Izumi, T., 2007:
Safety support for medical device: an outline revision and highlights of the medical law

Ichikawa, T., 2013:
Safety surgery is priority for anesthesiologists--the introduction of WHO SSSL checklist and surgical Apgar score

Sacks, G.S., 2012:
Safety surrounding parenteral nutrition systems

van der Maas, N.A.T.; David, S.; Kemmeren, J.M.; Vermeer-de Bondt, P.E., 2008 :
Safety surveillance in the National Vaccination Programme; fewer adverse events with the DTP-IPV-Hib vaccine after the transition to an acellular pertussis component in 2005

Caillet, Céline.; Durrieu, G.; Jacquet, A.; Faucher, A.; Ouaret, S.; Perrault-Pochat, M-Christine.; Kreft-Jaïs, C.; Castot, A.; Montastruc, J-Louis.; Autret-Leca, E.; Baldin B, B.; Bavoux, F.; Bénard-Laribière, A.; Biour, M.; Beyens, M.N.; Colin, F.; Cocquerel, A.; Crepin, S.; Décréau-Gaillon, G.; Dos Santos, S.; Eftekhari, P.; Favrelière, S.; Gautier, S.; Gras-Champel, V.; Javot, L.; Jean-Pastor, M.J.; Le Beller, C.; Lebrun-Vignes, B.; Millaret, A.; Perrazi, A.; Pinzani, V.; Riché, C.;, 2012:
Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France

Carcione, D.; Blyth, C.C.; Richmond, P.C.; Mak, D.B.; Effler, P.V., 2013:
Safety surveillance of influenza vaccine in pregnant women

Schuemie, M.J., 2012:
Safety surveillance of longitudinal databases: further methodological considerations

Norén, G.Niklas.; Hopstadius, J.; Bate, A.; Edwards, I.Ralph., 2011:
Safety surveillance of longitudinal databases: methodological considerations

Mischley, L.K.; Vespignani, M.F.; Finnell, J.S., 2013:
Safety survey of intranasal glutathione

Klein, I., 2012:
Safety switch for short-wave machine

Sibbitt, W.L.; Band, P.A.; Kettwich, L.G.; Sibbitt, C.R.; Sibbitt, L.J.; Bankhurst, A.D., 2011:
Safety syringes and anti-needlestick devices in orthopaedic surgery

Sivasankar, S.; Karmegam, K.; Bahri, M.T.Shamsul.; Naeini, H.Sadeghi.; Kulanthayan, S., 2014:
Safety system for child pillion riders of underbone motorcycles in Malaysia

Adnadjevic, D.; Lorrain, T.; Graven-Nielsen, T., 2015:
Safety system for moving coil pressure algometer

Reed, R.K.; Bell, J.C., 2013:
Safety systems and access control in the National Ignition Facility

Imamura, T.; Sakamoto, R.; Sasaki, T.; Kokumai, N.; Ohgitani, T.; Sawata, A.; Lin, Z.; Sakaguchi, M., 2011:
Safety test and field study of an inactivated oil-adjuvanted H5N1 avian influenza vaccine

Post, P.L., 2016:
Safety testing and use of insect cells for recombinant protein production

Giansanti, F.; Schiavone, N.; Papucci, L.; Bitossi, A.; Andreucci, E.; Pontenani, F.; Cutrì, M.; Menchini, U., 2015:
Safety testing of blue vital dyes using cell culture models

Montag, T.; Spreitzer, I.; Löschner, B.; Unkelbach, U.; Flory, E.; Sanzenbacher, R.; Schwanig, M.; Schneider, C.K., 2007:
Safety testing of cell-based medicinal products: opportunities for the monocyte activation test for pyrogens

Petrarca, R.; Richardson, M.; Douiri, A.; Nau, J.; McHugh, D.; Stangos, A.N.; Jackson, T.L., 2014:
Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results

Hillenkamp, J.; Dydykina, S.; Klettner, A.; Treumer, F.; Vasold, R.; Bäumler, W.; Roider, J., 2011:
Safety testing of indocyanine green with different surgical light sources and the protective effect of optical filters

Backes, J., 2007:
Safety testing of medical devices: IEC 62353 explained

Pang, K.Sandy., 2008:
Safety testing of metabolites: Expectations and outcomes

Birnbaum, L.S.; Stokes, W.S., 2010:
Safety testing: moving toward alternative methods

Larsson, L-Göran., 2008:
Safety thinking in surgery

Jeffs, L.; Kitto, S.; Merkley, J.; Lyons, R.F.; Bell, C.M., 2012:
Safety threats and opportunities to improve interfacility care transitions: insights from patients and family members

Nishida, K.; Kamei, M.; Du, Z-jiang.; Xie, P.; Yamamoto, T.; Suzuki, M.; Sakaguchi, H.; Nishida, K., 2011:
Safety threshold of intravitreal activated protein-C

Powell, A.G.M.T.; Paterson-Brown, S., 2011:
Safety through education. FY1 doctors still poor in prescribing intravenous fluids

Toft, B., 2011:
Safety through education. Human factors for all?

Thompson, M.J., 2011:
Safety through education. Prevention is better than the law

Staines, R., 2009:
Safety through equality

Ong, M-Sing.; Coiera, E., 2011:
Safety through redundancy: a case study of in-hospital patient transfers

Woo, E.; Virani, J., 2012 :
Safety tips for intense pulsed light therapy

Mulhern, B.; Lentz, T.J., 2010:
Safety tips for roadway work zones

Anonymous, 2008:
Safety tips for the nursery and around the house

Koukopoulos, P., 2007:
Safety training: we're lovin' it

Ujam, A.; Awad, Z.; Wong, G.; Tatla, T.; Farrell, R., 2012:
Safety trial of Floseal(®) haemostatic agent in head and neck surgery

Sofuni, A.; Moriyasu, F.; Sano, T.; Itokawa, F.; Tsuchiya, T.; Kurihara, T.; Ishii, K.; Tsuji, S.; Ikeuchi, N.; Tanaka, R.; Umeda, J.; Tonozuka, R.; Honjo, M.; Mukai, S.; Fujita, M.; Itoi, T., 2015:
Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer

Friedlander, J., 2014:
Safety under the sun

Gascón, P., 2008:
Safety update on erythropoiesis-stimulating agents: trials within and outside the accepted indications

Abshire, T., 2008:
Safety update on recombinant factor VIIa in the treatment of congenital and acquired hemophilia

Pedersen, M., 2007:
Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis

Abshire, T.; Kenet, G., 2008:
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors

Moltenis, Mélanie.; Valnet-Rabier, M-Blanche.; Leroy, Jël.; Kantelip, J-Pierre., 2013:
Safety update on vaccination during pregnancy

Blaiss, M.S., 2012:
Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis

Zheng, B-Hui.; Luo, J-Hong.; Fu, Q.; Qin, Y-Wen.; Hu, L-Lin., 2013:
Safety value of contaminant in water pollution accident based on human health risk

Hayashi, E.; Imai, T.; Niimi, H., 2011:
Safety verification for reuse of PET and glass bottles

Kato, S.; Andoh, H.; Gamoh, M.; Yamaguchi, T.; Murakawa, Y.; Shimodaira, H.; Takahashi, S.; Mori, T.; Ohori, H.; Maeda, S-ichi.; Suzuki, T.; Kato, S.; Akiyama, S.; Sasaki, Y.; Yoshioka, T.; Ishioka, C., 2012:
Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients

Scotland, G.S.; McNamee, P.; Peddie, V.L.; Bhattacharya, S., 2007:
Safety versus success in elective single embryo transfer: women's preferences for outcomes of in vitro fertilisation

Melander-Wikman, A.; Fältholm, Y.; Gard, G., 2008:
Safety vs. privacy: elderly persons' experiences of a mobile safety alarm

Braun, M., 2013:
Safety vs. safety

Mikkelsen, K.L.; Spangenberg, S.; Kines, P., 2011:
Safety walkarounds predict injury risk and reduce injury rates in the construction industry

Nonyelum, S.Catherine.; Nkem, N.; Ifeyinwa, C-Nwauche.; Orisakwe, O.Ebere., 2011:
Safety warnings and first aid instructions on consumer and pharmaceutical products in Nigeria: has there been an improvement?

Wray, K.; Rajab-Ali, R., 2014:
Safety watch: reducing constant observation through nurse empowerment and accountability

O'Dowd, A., 2009:
Safety watchdog warns of high dosage errors among children and young people

Luettel, D.; Bischler, A., 2011:
Safety when giving insulin in hospital

Emery, P.; Rigby, W.; Tak, P.P.; Dörner, T.; Olech, E.; Martin, C.; Millar, L.; Travers, H.; Fisheleva, E., 2014:
Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program

Carlson, J., 2013:
Safety woes. FDA finds deficiencies at 31 compounding factories

Winkel, N.C., 2018:
Safety work in the Netherlands during the war

Ludwick, R.; Meehan, A.; Zeller, R.; O'Toole, R., 2008:
Safety work: initiating, maintaining, and terminating restraints

Saxton, J.W.; Finkelstein, M.M., 2011:
Safety works: getting past the very thought of change

Aliber, J., 2012:
Safety zone

Saber, A.A.; Helbling, B.; Khaghany, K.; Nirmit, G.; Pimental, R.; McLeod, M.K., 2007:
Safety zone for splenic hilar control during splenectomy: a computed tomography scan mapping of the tail of the pancreas in relation to the splenic hilum

Saber, A.A.; Miller, L.; Helbling, B.; Nirmit, G.; Martinez, R.L.; Elgamal, M.; Khaghany, K.; Khater, U.M., 2008:
Safety zones for colorectal dissection: a CT scan mapping of the ureters relative to the colon and rectum

Byrnes, J., 2014:
Safety's impact on the value equation

Neuman, M.R., 2013:
Safety, BME style

Horowitz, N.S.; Penson, R.T.; Duda, D.G.; di Tomaso, E.; Boucher, Y.; Ancukiewicz, M.; Cohen, K.S.; Berlin, S.; Krasner, C.N.; Moses, M.A.; Jain, R.K., 2011:
Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma

Eren, O.Onder.; Ozturk, M.Akif.; Sonmez, O.Uysal.; Oyan, B., 2014:
Safety, Feasibility, and Efficacy of Capecitabine Maintenance in Patients With Advanced Gastric Cancer: A Retrospective Study

Bongers, K.T.; Schoon, Y.; Graauwmans, M.J.; Hoogsteen-Ossewaarde, M.E.; Olde Rikkert, M.G.M., 2016:
Safety, Feasibility, and Reliability of the Maximal Step Length, Gait Speed, and Chair Test Measured by Seniors Themselves: The Senior Step Study

Steele, A.Duncan.; Madhi, S.Ahmed.; Louw, C.Emily.; Bos, P.; Tumbo, J.M.; Werner, C.M.; Bicer, C.; De Vos, B.; Delem, A.; Han, H.Htay., 2011:
Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa

Kumarasamy, N.; Venkatesh, K.K.; Devaleenal, B.; Poongulali, S.; Yepthomi, T.; Solomon, S.; Flanigan, T.P.; Mayer, K.H., 2016 :
Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients

Basford, J.R.; Oh, J.K.; Allison, T.G.; Sheffield, C.G.; Manahan, B.G.; Hodge, D.O.; Tajik, A.Jamil.; Rodeheffer, R.J.; Tei, C., 2009:
Safety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: a pilot report

Topalian, S.L.; Hodi, F.Stephen.; Brahmer, J.R.; Gettinger, S.N.; Smith, D.C.; McDermott, D.F.; Powderly, J.D.; Carvajal, R.D.; Sosman, J.A.; Atkins, M.B.; Leming, P.D.; Spigel, D.R.; Antonia, S.J.; Horn, L.; Drake, C.G.; Pardoll, D.M.; Chen, L.; Sharfman, W.H.; Anders, R.A.; Taube, J.M.; McMiller, T.L.; Xu, H.; Korman, A.J.; Jure-Kunkel, M.; Agrawal, S.; McDonald, D.; Kollia, G.D.; Gupta, A.; Wigginton, J.M.; Sznol, M., 2012:
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Kibengo, F.M.; Ruzagira, E.; Katende, D.; Bwanika, A.N.; Bahemuka, U.; Haberer, J.E.; Bangsberg, D.R.; Barin, B.; Rooney, J.F.; Mark, D.; Chetty, P.; Fast, P.; Kamali, A.; Priddy, F.H., 2014:
Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial

Regev-Shoshani, G.; Vimalanathan, S.; Prema, D.; Church, J.S.; Reudink, M.W.; Nation, N.; Miller, C.C., 2014:
Safety, bioavailability and mechanism of action of nitric oxide to control Bovine Respiratory Disease Complex in calves entering a feedlot

Du, Y-rong.; Li, F.; Wang, X-bin.; Tang, Z-gang.; Tian, J.; Ba, J-tao.; Long, M-qing.; Zhang, J-bo., 2010:
Safety, biodistribution, and dosimetry of myocardial imaging agent 99Tc(m)N-NOET in healthy volunteers

Boulware, D.R., 2011:
Safety, censoring, and intent-to-treat analysis: dangers to generalizability

Mathias, J.M., 2013:
Safety, cost savings, simplicity back broader use of bloodless surgery

Rahman, K.Mizanur.; Arifeen, S.El.; Zaman, K.; Rahman, M.; Raqib, R.; Yunus, M.; Begum, N.; Islam, M.Shaheenul.; Sohel, B.Munir.; Rahman, M.; Venkatesan, M.; Hale, T.L.; Isenbarger, D.W.; Sansonetti, P.J.; Black, R.E.; Baqui, A.H., 2011:
Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh

Feldblum, P.J.; Odoyo-June, E.; Obiero, W.; Bailey, R.C.; Combes, S.; Hart, C.; Jou Lai, J.; Fischer, S.; Cherutich, P., 2014:
Safety, effectiveness and acceptability of the PrePex device for adult male circumcision in Kenya

Blencowe, H.; Kerac, M.; Molyneux, E., 2009:
Safety, effectiveness and barriers to follow-up using an 'early discharge' Kangaroo Care policy in a resource poor setting

Terhaer, F.K.; Bock, M.; Fartasch, Mé.; Gabard, B.; Elsner, P.; Kleesz, P.; Landeck, L.; Pohrt, U.; Seyfarth, F.; Schliemann, S.; Diepgen, T.L.; Zagrodnik, F.; John, S.Malte., 2011:
Safety, effectiveness and comparability of professional skin cleansers

Patel, S.; Hee, S.Wan.; Sandhu, H.; Yang, Y.; Underwood, M., 2015:
Safety, effectiveness, and cost effectiveness of decision aids still unclear

Tricco, A.C.; Ashoor, H.M.; Antony, J.; Beyene, J.; Veroniki, A.Angeliki.; Isaranuwatchai, W.; Harrington, A.; Wilson, C.; Tsouros, S.; Soobiah, C.; Yu, C.H.; Hutton, B.; Hoch, J.S.; Hemmelgarn, B.R.; Moher, D.; Majumdar, S.R.; Straus, S.E., 2015:
Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis

Villamizar, N.; Pryor, A.D., 2010:
Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus

Tricco, A.C.; Ashoor, H.M.; Soobiah, C.; Hemmelgarn, B.; Moher, D.; Hutton, B.; Yu, C.H.; Majumdar, S.R.; Straus, S.E., 2014:
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis

Kingsbury, D.J.; Bader-Meunier, B.; Patel, G.; Arora, V.; Kalabic, J.; Kupper, H., 2015:
Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years

Mathews, M.S.; Sharma, J.; Snyder, K.V.; Natarajan, S.K.; Siddiqui, A.H.; Hopkins, L.Nelson.; Levy, E.I., 2009:
Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset

Yoelin, S.; Walt, J.G.; Earl, M., 2010:
Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth

Diamantis, M.L.; Bartlett, B.L.; Tyring, S.K., 2009:
Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts

Aisien, A.O.; Enosolease, M.E., 2010:
Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital

Konstan, M.W.; Flume, P.A.; Kappler, M.; Chiron, Rël.; Higgins, M.; Brockhaus, F.; Zhang, J.; Angyalosi, G.; He, E.; Geller, D.E., 2011:
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

Lee, M.William., 2009:
Safety, efficacy and ethical issues regarding weight-loss medications

Elmi, A.; Kajbafzadeh, A-Mohammad.; Tourchi, A.; Talab, S.Shafaat.; Esfahani, S.Abdar., 2013:
Safety, efficacy and health related quality of life of autologous myoblast transplantation for treatment of urinary incontinence in children with bladder exstrophy-epispadias complex

Cremonesi, A.; Gieowarsingh, S.; Spagnolo, B.; Manetti, R.; Liso, A.; Furgieri, A.; Barattoni, M.Cristina.; Ghetti, L.; Tavazzi, L.; Castriota, F., 2010:
Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: the tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry)

Carranza-Lira, Sán., 2010:
Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review

Graziottin, A., 2008:
Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review

Bednarek, P.H.; Jensen, J.T., 2010:
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS

Benagiano, G.; Carrara, S.; Filippi, V., 2009:
Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives

Tomiyama, N.; Hidaka, M.; Hidaka, H.; Kawano, Y.; Hanada, N.; Kawaguchi, H.; Arimori, K.; Nakamura, C., 2010:
Safety, efficacy and pharmacokinetics of S-1 in a hemodialysis patient with advanced gastric cancer

Wasserman, R.L.; Church, J.A.; Stein, M.; Moy, J.; White, M.; Strausbaugh, S.; Schroeder, H.; Ballow, M.; Harris, J.; Melamed, I.; Elkayam, D.; Lumry, W.; Suez, D.; Rehman, S.M., 2013:
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency

Strumberg, D.; Schultheis, B.; Scheulen, M.E.; Hilger, R.A.; Krauss, J.; Marschner, N.; Lordick, F.; Bach, F.; Reuter, D.; Edler, L.; Mross, K., 2010:
Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

Valecha, N.; Srivastava, B.; Dubhashi, N.G.; Rao, B.H.Krishnamoorthy.; Kumar, A.; Ghosh, S.K.; Singh, J.Prakash.Narayan.; Kiechel, J.R.; Sharma, B.; Jullien, V.; Dash, A.P.; Taylor, W.R.J.; Anvikar, A.R., 2015:
Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in India

Conrozier, T.; Couris, C.Marie.; Mathieu, P.; Merle-Vincent, F.; Piperno, M.; Coury, F.; Belin, V.; Tebib, J.; Vignon, E., 2008:
Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice

Neunhoeffer, F.; Renk, H.; Hofbeck, M.; Grenz, C.; Haller, C.; Heimberg, E.; Gerbig, I.; Schlensak, C.; Kumpf, M., 2015:
Safety, efficacy and response to a hydrocortisone rescue therapy protocol in children with refractory hypotension after cardiopulmonal bypass

Thong, K.Y.; Jose, B.; Sukumar, N.; Cull, M.L.; Mills, A.P.; Sathyapalan, T.; Shafiq, W.; Rigby, A.S.; Walton, C.; Ryder, R.E.J.; Eliwe, M..H.; Chuni, P.; Hay, C.; Narayan, S.; Krishnan, S.; McGrane, D.; Sainsbury, C.; Fisher, M.; Eliot, G.; Shaikh, S.; Jones, S..L.; Milles, J..J.; Griffiths, U.; Colloby, M.; Harold, C.; Rangan, S.; Morrison, J.; Fisher, M.; McGrane, D.; Govindan, J.; Price, P.; Ahmed, S.; Gardner, A.; Brackenbridge, A.; Reid, A.; Piper-Smith, J.; Preston, J.; Field, B..C..T.; D, 2011:
Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*

Swaroop, A.; Bagchi, M.; Kumar, P.; Preuss, H.G.; Tiwari, K.; Marone, P.Ann.; Bagchi, D., 2015:
Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)

Heise, T.; Morrow, L.; Hompesch, M.; Häring, H-U.; Kapitza, C.; Abt, M.; Ramsauer, M.; Magnone, M-C.; Fuerst-Recktenwald, S., 2015:
Safety, efficacy and weight effect of two 11β-HSD1 inhibitors in metformin-treated patients with type 2 diabetes

Breech, L.L.; Braverman, P.K., 2010:
Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder

Lannfelt, L.; Blennow, K.; Zetterberg, H.; Batsman, S.; Ames, D.; Harrison, J.; Masters, C.L.; Targum, S.; Bush, A.I.; Murdoch, R.; Wilson, J.; Ritchie, C.W.; Lannfelt, L.; Nilsson, C.; Eriksson, S.; Pilenvik, E.; Minthon, L.; Are, K.; Haglund, A.; Båtsman, S.; Boundy, K.; Ames, D.; Brodaty, H.; Woodward, M.; Kurrle, S.; Drysdale, P.; Macfarlane, S., 2008:
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Weber, J.S.; Kudchadkar, R.Reiney.; Yu, B.; Gallenstein, D.; Horak, C.E.; Inzunza, H.David.; Zhao, X.; Martinez, A.J.; Wang, W.; Gibney, G.; Kroeger, J.; Eysmans, C.; Sarnaik, A.A.; Chen, Y.Ann., 2014:
Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma

Olesen, A.Sofie.; Lohse, L.; Dalgaard, M.Danner.; Woźniakowski, G.; Belsham, G.J.; Bøtner, A.; Rasmussen, T.Bruun., 2018:
Complete genome sequence of an African swine fever virus (ASFV POL/2015/Podlaskie) determined directly from pig erythrocyte-associated nucleic acid

Hardesty, D.A.; Thind, H.; Zabramski, J.M.; Spetzler, R.F.; Nakaji, P., 2015:
Safety, efficacy, and cost of intraoperative indocyanine green angiography compared to intraoperative catheter angiography in cerebral aneurysm surgery

McCullough, M.; Weber, C.; Leong, C.; Sharma, J., 2013:
Safety, efficacy, and cost savings of single parathyroid hormone measurement for risk stratification after total thyroidectomy

Tiwari, M.M.; Reynoso, J.F.; High, R.; Tsang, A.W.; Oleynikov, D., 2011:
Safety, efficacy, and cost-effectiveness of common laparoscopic procedures

Hamilton, D.Kojo.; Smith, J.S.; Reames, D.L.; Williams, B.J.; Chernavvsky, D.R.; Shaffrey, C.I., 2013:
Safety, efficacy, and dosing of recombinant human bone morphogenetic protein-2 for posterior cervical and cervicothoracic instrumented fusion with a minimum 2-year follow-up

Kiser, T.H.; Burch, J.C.; Klem, P.M.; Hassell, K.L., 2008:
Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia

Ray, J.B.; Ray, S., 2011:
Safety, efficacy, and durability of laparoscopic adjustable gastric banding in a single surgeon U.S. community practice

Qasem, Q.; Dooley, I.J.; D'Arcy, F.; O'Keefe, M., 2013:
Safety, efficacy, and effect of foldable phakic iris-claw intraocular lenses on higher-order aberrations: Two-year follow-up

Adiga, S.; Athreya, S., 2014:
Safety, efficacy, and feasibility of an ultra-low dose radiation protocol for CT-guided percutaneous needle biopsy of pulmonary lesions: initial experience

Mahmoud, A.F.; Massa, S.T.; Douberly, S.L.; Montes, M.L.; Ruckenstein, M.J., 2015:
Safety, efficacy, and hearing preservation using an integrated electro-acoustic stimulation hearing system

Jackson, L.A.; Gaglani, M.J.; Keyserling, H.L.; Balser, J.; Bouveret, N.; Fries, L.; Treanor, J.J., 2010:
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

Mahabadi, A.A.; Achenbach, S.; Burgstahler, C.; Dill, T.; Fischbach, R.; Knez, A.; Moshage, W.; Richartz, B.M.; Ropers, D.; Schröder, S.; Silber, S.; Möhlenkamp, S., 2011:
Safety, efficacy, and indications of beta-adrenergic receptor blockade to reduce heart rate prior to coronary CT angiography

Modi, S.S.; Davison, J.A.; Walters, T., 2011:
Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery

Guo, K.; Sun, J.; Qiao, Q.; Guo, N.; Guo, L., 2012:
Safety, efficacy, and modifications of the dermal bra technique for reduction mammaplasty and ptosis correction: a 10-year retrospective study

Sauer, R-Solange.; Krug, S.M.; Hackel, D.; Staat, C.; Konasin, N.; Yang, S.; Niedermirtl, B.; Bosten, J.; Günther, R.; Dabrowski, S.; Doppler, K.; Sommer, C.; Blasig, I.E.; Brack, A.; Rittner, H.L., 2015:
Safety, efficacy, and molecular mechanism of claudin-1-specific peptides to enhance blood-nerve-barrier permeability

Caperton, C.; Berman, B., 2011:
Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses

Page, M.A.; Fraunfelder, F.W., 2009:
Safety, efficacy, and patient acceptability of lidocaine hydrochloride ophthalmic gel as a topical ocular anesthetic for use in ophthalmic procedures

Kimer, N.; Krag, A.; Gluud, L.L., 2014:
Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy

Celio, L.; Ricchini, F.; De Braud, F., 2013:
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting

Hasan, R.; Ghanbari, H.; Feldman, D.; Menesses, D.; Rivas, D.; Zakhem, N.C.; Duarte, C.; Machado, C., 2012:
Safety, efficacy, and performance of implanted recycled cardiac rhythm management (CRM) devices in underprivileged patients

Blanco, Jé.Ramón.; Caro-Murillo, A.María.; Castaño, M.Angel.; Olalla, Ján.; Domingo, P.; Arazo, P.; Gómez-Sirvent, J.Luis.; Riera, M.; Pulido, F.; Vera, F.; Romero-Palacios, A.; Aguirrebengoa, K.; Portilla, Jín.; Ferrer, P.; Pedrol, E., 2014:
Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study

Wrishko, R.; Sorsaburu, S.; Wong, D.; Strawbridge, A.; McGill, J., 2010:
Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil

Lalezari, J.; Gathe, J.; Brinson, C.; Thompson, M.; Cohen, C.; Dejesus, E.; Galindez, J.; Ernst, J.A.; Martin, D.E.; Palleja, S.M., 2011:
Safety, efficacy, and pharmacokinetics of TBR-652, a CCR5/CCR2 antagonist, in HIV-1-infected, treatment-experienced, CCR5 antagonist-naive subjects

Jonas, M.M.; Kelly, D.; Pollack, H.; Mizerski, J.; Sorbel, J.; Frederick, D.; Mondou, E.; Rousseau, F.; Sokal, E., 2008:
Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B

Quiros, J.Antonio.; Heyman, M.B.; Pohl, J.F.; Attard, T.M.; Pieniaszek, H.J.; Bortey, E.; Walker, K.; Forbes, W.P., 2010:
Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study

Wall, D.A.; Chan, K.Wah.; Nieder, M.L.; Hayashi, R.J.; Yeager, A.M.; Kadota, R.; Przepiorka, D.; Mezzi, K.; Kletzel, M., 2010:
Safety, efficacy, and pharmacokinetics of intravenous busulfan in children undergoing allogeneic hematopoietic stem cell transplantation

Ford, N.; Lee, J.; Andrieux-Meyer, I.; Calmy, A., 2011:
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings

Wells, T.G.; Portman, R.; Norman, P.; Haertter, S.; Davidai, G.; Fei Wang, 2011:
Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension

Berkowitz, J.L.; Janik, J.E.; Stewart, D.M.; Jaffe, E.S.; Stetler-Stevenson, M.; Shih, J.H.; Fleisher, T.A.; Turner, M.; Urquhart, N.E.; Wharfe, G.H.; Figg, W.D.; Peer, C.J.; Goldman, C.K.; Waldmann, T.A.; Morris, J.C., 2015:
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma

Tomita, M.; Watabe, M.; Yukawa, S.; Nakamura, N.; Nakamura, T.; Magnago, T., 2014:
Safety, efficacy, and predictability of laser in situ keratomileusis to correct myopia or myopic astigmatism with a 750 Hz scanning-spot laser system

Nasser, F.; Cavalcante, R.N.; Affonso, B.B.; Messina, M.L.; Carnevale, F.C.; de Gregorio, M.A., 2014 :
Safety, efficacy, and prognostic factors in endovascular treatment of pelvic congestion syndrome

Matsuo, T.; Uchida, T.; Takarabe, K., 2010:
Safety, efficacy, and quality control of a photoelectric dye-based retinal prosthesis (Okayama University-type retinal prosthesis) as a medical device

Mason, J.O.; Neimkin, M.G.; Mason, J.O.; Friedman, D.A.; Feist, R.M.; Thomley, M.L.; Albert, M.A., 2015:
Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters

Basnet, S.; Mander, G.; Andoh, J.; Klaska, H.; Verhulst, S.; Koirala, J., 2012:
Safety, efficacy, and tolerability of early initiation of noninvasive positive pressure ventilation in pediatric patients admitted with status asthmaticus: a pilot study

Sclafani, A.P., 2012:
Safety, efficacy, and utility of platelet-rich fibrin matrix in facial plastic surgery

Vaishampayan, U.N.; Burger, A.M.; Sausville, E.A.; Heilbrun, L.K.; Li, J.; Horiba, M.Naomi.; Egorin, M.J.; Ivy, P.; Pacey, S.; Lorusso, P.M., 2010:
Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin

Khoramnia, R.; Salgado, J.P.; Wuellner, C.; Donitzky, C.; Lohmann, C.P.; Winkler von Mohrenfels, C., 2012:
Safety, efficacy, predictability and stability of laser in situ keratomileusis (LASIK) with a 1000-Hz scanning spot excimer laser

Mirski, M.A.; Pandian, V.; Bhatti, N.; Haut, E.; Feller-Kopman, D.; Morad, A.; Haider, A.; Schiavi, A.; Efron, D.; Ulatowski, J.; Yarmus, L.; Stevens, K.A.; Miller, C.A.; Papangelou, A.; Vaswani, R.; Kalmar, C.; Gupta, S.; Intihar, P.; Mack, S.; Rushing, A.P.; Chi, A.; Roberts, V.J., 2012:
Safety, efficiency, and cost-effectiveness of a multidisciplinary percutaneous tracheostomy program

Lippa, C.F., 2008:
Safety, end-of-life issues, and dealing with sexually inappropriate behavior in dementia patients

Highsmith, M.Jason.; Kahle, J.T.; Bongiorni, D.R.; Sutton, B.S.; Groer, S.; Kaufman, K.R., 2011:
Safety, energy efficiency, and cost efficacy of the C-Leg for transfemoral amputees: A review of the literature

Rossi, S.; Hallett, M.; Rossini, P.M.; Pascual-Leone, A., 2009:
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research

Fox, A.; Berrick, J.Duerr.; Frasch, K., 2008:
Safety, family, permanency, and child well-being: what we can learn from children

Thudium, M.O.; von Lehe, M.; Wessling, C.; Schoene-Bake, J-Christoph.; Soehle, M., 2015:
Safety, feasibility and complications during resective pediatric epilepsy surgery: a retrospective analysis

Black, S.; Zulliger, R.; Myer, L.; Marcus, R.; Jeneker, S.; Taliep, R.; Pienaar, D.; Wood, R.; Bekker, L-Gail., 2013:
Safety, feasibility and efficacy of a rapid ART initiation in pregnancy pilot programme in Cape Town, South Africa

Devière, J.; Ojeda Valdes, G.; Cuevas Herrera, L.; Closset, J.; Le Moine, O.; Eisendrath, P.; Moreno, C.; Dugardeyn, S.; Barea, M.; de la Torre, R.; Edmundowicz, S.; Scott, S., 2007:
Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study

Phongsavan, K.; Phengsavanh, A.; Wahlström, R.; Marions, L., 2011:
Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos

Lin, E.; Snell, G.I.; Levvey, B.J.; Mifsud, N.; Paul, M.; Buckland, M.R.; Gooi, J.; Marasco, S.; Sharland, A.F.; Myles, P.S., 2015:
Safety, feasibility, and effect of remote ischemic conditioning in patients undergoing lung transplantation

Matheny, K.E.; Carter, K.B.; Tseng, E.Y.; Fong, K.J., 2015:
Safety, feasibility, and efficacy of placement of steroid-eluting bioabsorbable sinus implants in the office setting: a prospective case series

Havel, C.; Berzlanovich, A.; Sterz, F.; Domanovits, H.; Herkner, H.; Zeiner, A.; Behringer, W.; Laggner, A.N., 2008:
Safety, feasibility, and hemodynamic and blood flow effects of active compression-decompression of thorax and abdomen in patients with cardiac arrest

Zhu, Y-Qi.; Gu, B-Xian.; Li, M-Hua.; Wang, W.; Cheng, Y-Sheng.; Tan, H-Qiao.; Wang, J-Bo.; Zhang, P-Lei.; Ma, L-Ting., 2011:
Safety, feasibility, and mid-term follow-up of Willis stent graft placement in the treatment of symptomatic complicated intra- or extra-cranial aneurysms: a multicenter experience

Dankiewicz, J.; Schmidbauer, S.; Nielsen, N.; Kern, K.B.; Mooney, M.R.; Stammet, P.; Riker, R.R.; Rubertsson, S.; Seder, D.; Smid, O.; Sunde, K.; Søreide, E.; Unger, B.T.; Friberg, H., 2015:
Safety, feasibility, and outcomes of induced hypothermia therapy following in-hospital cardiac arrest-evaluation of a large prospective registry*

Soop, M.; Larson, D.W.; Malireddy, K.; Cima, R.R.; Young-Fadok, T.M.; Dozois, E.J., 2009:
Safety, feasibility, and short-term outcomes of laparoscopically assisted primary ileocolic resection for Crohn's disease

Gianotti, L.; Nespoli, L.; Torselli, L.; Panelli, M.; Nespoli, A., 2011:
Safety, feasibility, and tolerance of early oral feeding after colorectal resection outside an enhanced recovery after surgery (ERAS) program

Morinville, Véronique.D.; Paquin, S.C.; Sahai, A.V., 2011:
Safety, feasibility, and usefulness of rectal endoscopic ultrasonography for pediatric anal and perianal complaints

Torres, Nás.I.; Noll, K.Sutyak.; Xu, S.; Li, J.; Huang, Q.; Sinko, P.J.; Wachsman, Mónica.B.; Chikindas, M.L., 2013:
Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1

Matern, U.; Koneczny, S., 2007:
Safety, hazards and ergonomics in the operating room

Jean-Baptiste, E.; Blanchemain, N.; Martel, B.; Neut, C.; Hildebrand, H.F.; Haulon, S., 2012:
Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies

Bodner, T.; Kraner, M.; Bradford, B.; Hammer, L.; Truxillo, D., 2015:
Safety, health, and well-being of municipal utility and construction workers

Rolland, J., 2014:
Safety, hope, and healing: a unique perspective

Chotpitayasunondh, T.; Thisyakorn, U.; Pancharoen, C.; Pepin, S.; Nougarede, N., 2009:
Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children

Hata, A.; Inoue, F.; Yamasaki, M.; Fujikawa, J.; Kawasaki, Y.; Hamamoto, Y.; Honjo, S.; Moriishi, E.; Mori, Y.; Koshiyama, H., 2014:
Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus

Chen, G.L.; Lamirande, E.W.; Jin, H.; Kemble, G.; Subbarao, K., 2010:
Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets

van Damme, P.; Kafeja, F.; Anemona, A.; Basile, V.; Hilbert, A.Katrin.; De Coster, I.; Rondini, S.; Micoli, F.; Qasim Khan, R.M.; Marchetti, E.; Di Cioccio, V.; Saul, A.; Martin, L.B.; Podda, A., 2012:
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults

Aziz-Boaron, O.; Leibovitz, K.; Gelman, B.; Kedmi, M.; Klement, E., 2014:
Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral fever vaccine

Aide, P.; Aponte, J.J.; Renom, M.; Nhampossa, T.; Sacarlal, J.; Mandomando, I.; Bassat, Q.; Manaca, M.Nélia.; Leach, A.; Lievens, M.; Vekemans, J.; Dubois, M-Claude.; Loucq, C.; Ballou, W.Ripley.; Cohen, J.; Alonso, P.L., 2011:
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial

Boffito, M.; Fox, J.; Bowman, C.; Fisher, M.; Orkin, C.; Wilkins, E.; Jackson, A.; Pleguezuelos, O.; Robinson, S.; Stoloff, G.A.; Caparrós-Wanderley, W., 2014:
Safety, immunogenicity and efficacy assessment of HIV immunotherapy in a multi-centre, double-blind, randomised, Placebo-controlled Phase Ib human trial

da Costa, V.G.; Marques-Silva, A.C.; Floriano, V.G.; Moreli, M.L., 2015:
Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials

De Rose, R.; Mason, R.D.; Loh, L.; Peut, V.; Smith, M.Z.; Fernandez, C.S.; Alcantara, S.; Amarasena, T.; Reece, J.; Seddiki, N.; Kelleher, A.D.; Zaunders, J.; Kent, S.J., 2009:
Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques

Nunes, M.C.; Madhi, S.A., 2012:
Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals

Haag-Weber, M.; Eckardt, K-Uwe.; Hörl, W.H.; Roger, S.D.; Vetter, A.; Roth, K., 2012:
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study

Knuf, M.; Zepp, F.; Meyer, C.U.; Habermehl, P.; Maurer, L.; Burow, H-Michael.; Behre, U.; Janssens, M.; Willems, P.; Bisanz, H.; Vetter, V.; Schmidt-Ott, R., 2011:
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months

Liakou, C.D.; Askiti, V.; Mitsioni, A.; Stefanidis, C.J.; Theodoridou, M.C.; Spoulou, V.I., 2012:
Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome

Berglund, J.; Vink, P.; Tavares Da Silva, F.; Lestrate, P.; Boutriau, D., 2014:
Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults

Muñoz, N.; Manalastas, R.; Pitisuttithum, P.; Tresukosol, D.; Monsonego, J.; Ault, K.; Clavel, C.; Luna, J.; Myers, E.; Hood, S.; Bautista, O.; Bryan, J.; Taddeo, F.J.; Esser, M.T.; Vuocolo, S.; Haupt, R.M.; Barr, E.; Saah, A., 2009:
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial

Lukashevich, I.S.; Carrion, R.; Salvato, M.S.; Mansfield, K.; Brasky, K.; Zapata, J.; Cairo, C.; Goicochea, M.; Hoosien, G.E.; Ticer, A.; Bryant, J.; Davis, H.; Hammamieh, R.; Mayda, M.; Jett, M.; Patterson, J., 2008:
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates

Araujo, E.C.; Clemens, S.Ann.C.; Oliveira, C.S.; Justino, M.Cleonice.A.; Rubio, P.; Gabbay, Y.B.; da Silva, V.B.; Mascarenhas, J.D.P.; Noronha, Vânia.L.; Clemens, R.; Gusmão, R.Helena.P.; Sanchez, N.; Monteiro, T.Antônia.F.; Linhares, A.C., 2007:
Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants

Greenberg, R.N.; Overton, E.Turner.; Haas, D.W.; Frank, I.; Goldman, M.; von Krempelhuber, A.; Virgin, G.; Bädeker, N.; Vollmar, J.; Chaplin, P., 2013:
Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects

Richmond, P.C.; Marshall, H.S.; Nissen, M.D.; Jiang, Q.; Jansen, K.U.; Garcés-Sánchez, M.; Martinón-Torres, F.; Beeslaar, J.; Szenborn, L.; Wysocki, J.; Eiden, J.; Harris, S.L.; Jones, T.R.; Perez, J.L.; Nolan, T.; Nissen, M.; Richmond, P.; Marshall, H.; Szenborn, L.; Szymanski, H.; Pejcz, J.; Tetiurka, B.; Dziduch, J.; Hasiec, B.; Czajka, H.; Jackowska, T.; Brzostek, J.; Bieganskiego, W.; Majda-Stanislawska, E.; Witor, A.; Kopinska, E.; Konior, R.; Wysocki, J.; Blanco, O.; Rojo, P.; Amador,, 2012:
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

Scheifele, D.W.; McNeil, S.A.; Ward, B.J.; Dionne, M.; Cooper, C.; Coleman, B.; Loeb, M.; Rubinstein, E.; McElhaney, J.; Hatchette, T.; Li, Y.; Montomoli, E.; Schneeberg, A.; Bettinger, J.A.; Halperin, S.A.; Langley, J.; Smith, B.; Quach, C.; Papenburg, J.; Beauchesne, Aé.; Gilca, V.; De Serres, G.; McGeer, A.; Hammond, G.; Aoki, F.; Stiver, G.; Yu, S.; Bastien, N.; Lapini, G.; Sbragi, S., 2014:
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison

Anonymous, 2007:
Safety, in their own words. How ambulance manufacturers are helping you stay safe

Edeki, T.; Kujacic, M.; Broadhurst, H.; Li, J.; Sunzel, M., 2015:
Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume

Weld, L.R.; Nwoye, U.O.; Knight, R.B.; Baumgartner, T.S.; Ebertowski, J.S.; Stringer, M.T.; Kasprenski, M.C.; Weld, K.J., 2014:
Safety, minimization, and awareness radiation training reduces fluoroscopy time during unilateral ureteroscopy

Kremenchutzky, M., 2011:
Safety, not only efficacy still to be proven for controversial new MS treatment

Mathus-Vliegen, E.M.H.; van der Vliet, K., 2013:
Safety, patient's tolerance, and efficacy of a 2-liter vitamin C-enriched macrogol bowel preparation: a randomized, endoscopist-blinded prospective comparison with a 4-liter macrogol solution

Mallon, G.P., 2010:
Safety, permanency, and well-being revisited

Boulet, L-Philippe.; Lemière, C.; Gauvreau, G.; Olivenstein, R.; Lougheed, D.; Paradis, B.; O'Byrne, P.; Pageau, Ré.; Renzi, P.M., 2010:
Safety, pharmacodynamics and pharmacokinetics of TPI 1020 in smokers with asthma

Chen, H.; Qiao, J.; Li, Q.; Deng, J.; Tan, Z.; Guo, T.; Li, W., 2011 :
Safety, pharmacokinetic and pharmacodynamic studies of batifiban injection following single- and multiple-dose administration to healthy Chinese subjects

Thuita, J.K.; Wolf, K.K.; Murilla, G.A.; Liu, Q.; Mutuku, J.N.; Chen, Y.; Bridges, A.S.; Mdachi, R.E.; Ismail, M.A.; Ching, S.; Boykin, D.W.; Hall, J.Edwin.; Tidwell, R.R.; Paine, M.F.; Brun, R.; Wang, M.Zhuo., 2013:
Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis

Meininger, V.; Pradat, P-François.; Corse, A.; Al-Sarraj, S.; Rix Brooks, B.; Caress, J.B.; Cudkowicz, M.; Kolb, S.J.; Lange, D.; Leigh, P.Nigel.; Meyer, T.; Milleri, S.; Morrison, K.E.; Orrell, R.W.; Peters, G.; Rothstein, J.D.; Shefner, J.; Lavrov, A.; Williams, N.; Overend, P.; Price, J.; Bates, S.; Bullman, J.; Krull, D.; Berges, A.; Abila, B.; Meno-Tetang, G.; Wurthner, J., 2015:
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial

Kovalchin, J.; Krieger, J.; Collins, K.; Genova, M.; Augustyniak, M.; Masci, A.; Avril, T.; Gandon, G.; Patat, A.; Fauchoux, N.; Toutin, C.; Lacoste, E.; Patel, U.; Mascioli, E.; Zanelli, E., 2011:
Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers

Infante, J.R.; Camidge, D.Ross.; Mileshkin, L.R.; Chen, E.X.; Hicks, R.J.; Rischin, D.; Fingert, H.; Pierce, K.J.; Xu, H.; Roberts, W.Gregory.; Shreeve, S.Martin.; Burris, H.A.; Siu, L.L., 2012:
Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors

Schwartz, S.L.; Akinlade, B.; Klasen, S.; Kowalski, D.; Zhang, W.; Wilpshaar, W., 2012:
Safety, pharmacokinetic, and pharmacodynamic profiles of ipragliflozin (ASP1941), a novel and selective inhibitor of sodium-dependent glucose co-transporter 2, in patients with type 2 diabetes mellitus

Zheng, M.; Appel, L.; Luo, F.; Lane, R.; Burt, D.; Risinger, R.; Antoni, G.; Cahir, M.; Keswani, S.; Hayes, W.; Bhagwagar, Z., 2015:
Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836

Ballow, C.; Leh, A.; Slentz-Kesler, K.; Yan, J.; Haughey, D.; Bernton, E., 2013:
Safety, pharmacokinetic, immunogenicity, and pharmacodynamic responses in healthy volunteers following a single intravenous injection of purified staphylococcal protein A

Erhardt, A.; Deterding, K.; Benhamou, Y.; Reiser, M.; Forns, X.; Pol, S.; Calleja, Jé.Luis.; Ross, S.; Spangenberg, H.Christian.; Garcia-Samaniego, J.; Fuchs, M.; Enríquez, J.; Wiegand, J.; Stern, J.; Wu, K.; Kukolj, G.; Marquis, M.; Beaulieu, P.; Nehmiz, G.; Steffgen, Jürgen., 2009:
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment

Devalapally, H.; Rajan, K.Subramanian.; Akkinepally, R.Rao.; Devarakonda, R.Krishna., 2008:
Safety, pharmacokinetics and biodistribution studies of a beta-galactoside prodrug of doxorubicin for improvement of tumor selective chemotherapy

Ades, V., 2011:
Safety, pharmacokinetics and efficacy of artemisinins in pregnancy

Spira, J.; Plyushch, O.; Zozulya, N.; Yatuv, R.; Dayan, I.; Bleicher, A.; Robinson, M.; Baru, M., 2011:
Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study

Vicari, A.P.; Schmalbach, T.; Lekstrom-Himes, J.; Morris, M.Louise.; Al-Adhami, M.J.; Laframboise, C.; Leese, P.; Krieg, A.M.; Efler, S.M.; Davis, H.L., 2007:
Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist

Lopatin, U.; Wolfgang, G.; Tumas, D.; Frey, C.R.; Ohmstede, C.; Hesselgesser, J.; Kearney, B.; Moorehead, L.; Subramanian, G.Mani.; McHutchison, J.G., 2013:
Safety, pharmacokinetics and pharmacodynamics of GS-9620, an oral Toll-like receptor 7 agonist

Schmitt, C.; Charoin-Pannier, A.; McIntyre, C.; Zandt, H.; Ciorciaro, C.; Winters, K.; Pepper, T., 2012:
Safety, pharmacokinetics and pharmacodynamics of multiple ascending doses of R1663, an oral factor Xa inhibitor, in healthy young subjects coupled with exploration of influence of gender and age

Jiang, J.; Hu, Y.; Zhang, J.; Yang, J.; Mueck, W.; Kubitza, D.; Bauer, R.J.; Meng, L.; Hu, P., 2010:
Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects

Zhao, X.; Sun, P.; Zhou, Y.; Liu, Y.; Zhang, H.; Mueck, W.; Kubitza, D.; Bauer, R.J.; Zhang, H.; Cui, Y., 2010:
Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects

Lawitz, E.; Gruener, D.; Marbury, T.; Hill, J.; Webster, L.; Hassman, D.; Nguyen, A-Hoa.; Pflanz, S.; Mogalian, E.; Gaggar, A.; Massetto, B.; Subramanian, G.Mani.; McHutchison, J.G.; Jacobson, I.M.; Freilich, B.; Rodriguez-Torres, M., 2016:
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C

Sardh, E.; Rejkjaer, L.; Andersson, D.E.H.; Harper, P., 2007:
Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion

Yamada, I.; Suzuki, F.; Kamiya, N.; Aoki, K.; Sakurai, Y.; Kano, M.; Matsui, H.; Kumada, H., 2012:
Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection

Hickman, M.A.; Cox, S.R.; Mahabir, S.; Miskell, C.; Lin, J.; Bunger, A.; McCall, R.B., 2008:
Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats

Kurzrock, R.; Goel, S.; Wheler, J.; Hong, D.; Fu, S.; Rezai, K.; Morgan-Linnell, S.K.; Urien, S.; Mani, S.; Chaudhary, I.; Ghalib, M.H.; Buchbinder, A.; Lokiec, Fçois.; Mulcahy, M., 2013:
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies

Kurzrock, R.; Gabrail, N.; Chandhasin, C.; Moulder, S.; Smith, C.; Brenner, A.; Sankhala, K.; Mita, A.; Elian, K.; Bouchard, D.; Sarantopoulos, J., 2012:
Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors

Jacobson, J.M.; Kuritzkes, D.R.; Godofsky, E.; DeJesus, E.; Larson, J.A.; Weinheimer, S.P.; Lewis, S.T., 2008:
Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults

Herbst, R.S.; Hong, D.; Chap, L.; Kurzrock, R.; Jackson, E.; Silverman, J.M.; Rasmussen, E.; Sun, Y-Nien.; Zhong, D.; Hwang, Y.C.; Evelhoch, J.L.; Oliner, J.D.; Le, N.; Rosen, L.S., 2009:
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors

Lawitz, E.; Godofsky, E.; Rouzier, R.; Marbury, T.; Nguyen, T.; Ke, J.; Huang, M.; Praestgaard, J.; Serra, D.; Evans, T.G., 2011:
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy

Emu, B.; Luca, D.; Offutt, C.; Grogan, J.L.; Rojkovich, B.; Williams, M.B.; Tang, M.T.; Xiao, J.; Lee, J.H.; Davis, J.C., 2012:
Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial

Rosen, L.S.; Kurzrock, R.; Mulay, M.; Van Vugt, A.; Purdom, M.; Ng, C.; Silverman, J.; Koutsoukos, A.; Sun, Y-Nien.; Bass, M.B.; Xu, R.Y.; Polverino, A.; Wiezorek, J.S.; Chang, D.D.; Benjamin, R.; Herbst, R.S., 2007:
Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors

Batist, G.; Gelmon, K.A.; Chi, K.N.; Miller, W.H.; Chia, S.K.L.; Mayer, L.D.; Swenson, C.E.; Janoff, A.S.; Louie, A.C., 2009:
Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors

Berg, S.L.; Cairo, M.S.; Russell, H.; Ayello, J.; Ingle, A.Mark.; Lau, H.; Chen, N.; Adamson, P.C.; Blaney, S.M., 2011:
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report

Gordon, M.S.; Sweeney, C.S.; Mendelson, D.S.; Eckhardt, S.Gail.; Anderson, A.; Beaupre, D.M.; Branstetter, D.; Burgess, T.L.; Coxon, A.; Deng, H.; Kaplan-Lefko, P.; Leitch, I.M.; Oliner, K.S.; Yan, L.; Zhu, M.; Gore, L., 2010:
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors

Cramer, S.C.; Abila, B.; Scott, N.E.; Simeoni, M.; Enney, L.A., 2013:
Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with stroke

Sasaki, T.; Seino, Y.; Fukatsu, A.; Sakai, S.; Samukawa, Y., 2015:
Safety, pharmacokinetics, and pharmacodynamics of single and multiple luseogliflozin dosing in healthy Japanese males: a randomized, single-blind, placebo-controlled trial

Katz, A.; Udata, C.; Ott, E.; Hickey, L.; Burczynski, M.E.; Burghart, P.; Vesterqvist, O.; Meng, X., 2009:
Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants

Karp, D.D.; Pollak, M.N.; Cohen, R.B.; Eisenberg, P.D.; Haluska, P.; Yin, D.; Lipton, A.; Demers, L.; Leitzel, K.; Hixon, M.L.; Terstappen, L.W.; Garland, L.; Paz-Ares, L.G.; Cardenal, F.; Langer, C.J.; Gualberto, A., 2010:
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

Olmos, D.; Postel-Vinay, S.; Molife, L.Rhoda.; Okuno, S.H.; Schuetze, S.M.; Paccagnella, M.Luisa.; Batzel, G.N.; Yin, D.; Pritchard-Jones, K.; Judson, I.; Worden, F.P.; Gualberto, A.; Scurr, M.; de Bono, J.S.; Haluska, P., 2010:
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

Strumberg, D.; Clark, J.W.; Awada, A.; Moore, M.J.; Richly, H.; Hendlisz, A.; Hirte, H.W.; Eder, J.P.; Lenz, H-Josef.; Schwartz, B., 2007:
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors

Khwaja, O.S.; Ho, E.; Barnes, K.V.; O'Leary, H.M.; Pereira, L.M.; Finkelstein, Y.; Nelson, C.A.; Vogel-Farley, V.; DeGregorio, G.; Holm, I.A.; Khatwa, U.; Kapur, K.; Alexander, M.E.; Finnegan, D.M.; Cantwell, N.G.; Walco, A.C.; Rappaport, L.; Gregas, M.; Fichorova, R.N.; Shannon, M.W.; Sur, M.; Kaufmann, W.E., 2014:
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome

Advani, A.; Coiffier, B.; Czuczman, M.S.; Dreyling, M.; Foran, J.; Gine, E.; Gisselbrecht, C.; Ketterer, N.; Nasta, S.; Rohatiner, A.; Schmidt-Wolf, I.G.H.; Schuler, M.; Sierra, J.; Smith, M.R.; Verhoef, G.; Winter, J.N.; Boni, J.; Vandendries, E.; Shapiro, M.; Fayad, L., 2010:
Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study

Bendell, J.C.; Gordon, M.S.; Hurwitz, H.I.; Jones, S.F.; Mendelson, D.S.; Blobe, G.C.; Agarwal, N.; Condon, C.H.; Wilson, D.; Pearsall, A.E.; Yang, Y.; McClure, T.; Attie, K.M.; Sherman, M.L.; Sharma, S., 2014:
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer

Westerberg, G.; Chiesa, J.A.; Andersen, C.A.; Diamanti, D.; Magnoni, L.; Pollio, G.; Darpo, B.; Zhou, M., 2015:
Safety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1 inhibitor selisistat in healthy volunteers

Melissas, J., 2009:
Safety, quality and excellence in bariatric surgery

Grose, A., 2015:
Safety, quality, compassion… and cost

El Sahly, H.M.; Atmar, R.L.; Patel, S.M.; Wells, J.M.; Cate, T.; Ho, M.; Guo, K.; Pasetti, M.F.; Lewis, D.E.; Sztein, M.B.; Keitel, W.A., 2009 :
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans

Dicko, A.; Santara, G.; Mahamar, A.; Sidibe, Y.; Barry, A.; Dicko, Y.; Diallo, A.; Dolo, A.; Doumbo, O.; Shafi, F.; François, N.; Strezova, A.; Borys, D.; Schuerman, L., 2014:
Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children

Leroux-Roels, G.; Maes, C.; De Boever, F.; Traskine, M.; Rüggeberg, J.U.; Borys, D., 2015:
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study

Campbell, J.D.; Clement, K.H.Long.; Wasserman, S.S.; Donegan, S.; Chrisley, L.; Kotloff, K.L., 2007:
Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults

Omenaca, F.; Sarlangue, J.; Szenborn, L.; Nogueira, M.; Suryakiran, P.V.; Smolenov, I.V.; Han, H.H.; Tejedor, J.C.; Castro, J.; Arístegui, J.; Centeno, F.; Merino, Jé.M.; Moreno-Pérez, D.; Díez-Delgado, J.; Ruiz-Contreras, Jús.; Carbonell, X.; Román, E.; Pajek, B.; Slaskie, S.; Wysocki, J.; Czajka, H.; Barroso, R.; Fonseca, F.; Areias, A.; Dinis, M.Júlio., 2012:
Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study

Lim, F.Seng.; Han, H.Htay.; Bock, H.L., 2008:
Safety, reactogenicity and immunogenicity of the live attenuated combined measles, mumps and rubella vaccine containing the RIT 4385 mumps strain in healthy Singaporean children

Postgate, A.Jonathan.; Burling, D.; Gupta, A.; Fitzpatrick, A.; Fraser, C., 2008:
Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review

Gridelli, C.; de Marinis, F.; Pujol, J-Louis.; Reck, M.; Ramlau, R.; Parente, B.; Pieters, T.; Middleton, G.; Corral, J.; Winfree, K.; Melemed, S.; Zimmermann, A.; John, W.; Beyrer, J.; Chouaki, N.; Visseren-Grul, C.; Paz-Ares, L.G., 2013:
Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

Macpherson, J.A.E., 2008:
Safety, risk acceptability, and morality

Smith-Merry, J.; Caple, A., 2014:
Safety, risk and mental health: decision-making processes prescribed by Australian mental health legislation

Cavanagh, H.Dwight.; Holden, B., 2007:
Safety, safety, safety

Arcury, T.A.; Weir, M.M.; Summers, P.; Chen, H.; Bailey, M.; Wiggins, M.F.; Bischoff, W.E.; Quandt, S.A., 2012:
Safety, security, hygiene and privacy in migrant farmworker housing

Sommavilla, B.; Jørgensen, C.; Jensen, K., 2008:
Safety, simplicity and convenience of a modified prefilled insulin pen

Taschuk, R.; Marciniuk, K.; Määttänen, P.; Madampage, C.; Hedlin, P.; Potter, A.; Lee, J.; Cashman, N.R.; Griebel, P.J.; Napper, S., 2015:
Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitope

Kesselheim, A., 2011:
Safety, supply, and suits--litigation and the vaccine industry

Asma, S.; Boga, C.; Ozdogu, H., 2009:
Safety, therapeutic effectiveness, and cost of parenteral iron therapy

Benbow, M., 2014:
Safety, tolerability and acceptability of KTwo

Loriot, Y.; Fizazi, K.; Jones, R.J.; Van den Brande, J.; Molife, R.L.; Omlin, A.; James, N.D.; Baskin-Bey, E.; Heeringa, M.; Baron, B.; Holtkamp, G.M.; Ouatas, T.; De Bono, J.S., 2015 :
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study

Noberasco, C.; Spitaleri, G.; Mancuso, P.; Zorzino, L.; Radice, D.; Milani, A.; Rocca, A.; Bertolini, F.; Sandri, M.Teresa.; Curigliano, G.; de Pas, T.; Jemos, C.; Omodeo Salè, E.; Boselli, S.; de Braud, F., 2010:
Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents

Li, H-Chuan.; Cheng, Y-Ping.; Yang, C-Jui., 2014:
Safety, tolerability and effectiveness of HIV non-occupational prophylaxis in Taiwan

Sherrod, C.; Johnson, D.; Chester, B., 2016:
Safety, tolerability and effectiveness of an ergonomic intervention with chiropractic care for knowledge workers with upper-extremity musculoskeletal disorders: a prospective case series

Kumarasamy, N.; Venkatesh, K.K.; Devaleenol, B.; Poongulali, S.; Mothi, S.N.; Solomon, S., 2008:
Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India

Witthöft, T.; Möller, B.; Wiedmann, K.H.; Mauss, S.; Link, R.; Lohmeyer, J.; Lafrenz, M.; Gelbmann, C.M.; Hüppe, D.; Niederau, C.; Alshuth, U., 2007:
Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial

Passali, D.; Mösges, R.; Passali, G.C.; Passali, F.M.; Ayoko, G.; Bellussi, L., 2011:
Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedules

Gaggar, A.; Coeshott, C.; Apelian, D.; Rodell, T.; Armstrong, B.R.; Shen, G.; Subramanian, G.Mani.; McHutchison, J.G., 2015:
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study

Van Damme, P.; Minervini, G.; Liss, C.L.; McCarson, B.; Vesikari, T.; Boslego, J.W.; Bhuyan, P.K., 2008 :
Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults

Shefner, J.; Cedarbaum, J.M.; Cudkowicz, M.E.; Maragakis, N.; Lee, J.; Jones, D.; Watson, M.Lou.; Mahoney, K.; Chen, M.; Saikali, K.; Mao, J.; Russell, A.J.; Hansen, R.L.; Malik, F.; Wolff, A.A.; Atassi, N.; Bedlack, R.; Boylan, K.; Bradshaw, D.; Goslin, K.; Heiman Patterson, T.; Jackson, C.; Kasarskis, E.J.; Katz, J.; Levine, T.; Maragakis, N.J.; Pestronk, A.; Simmons, Z., 2013:
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis

Saha, N.; Moehrle, J.J.; Zutshi, A.; Sharma, P.; Kaur, P.; Iyer, S.S., 2014:
Safety, tolerability and pharmacokinetic profile of single and multiple oral doses of arterolane (RBx11160) maleate in healthy subjects

Li, Q.; Qiao, J.; Deng, J.; Zeng, T.; Zhou, P.; Li, W., 2011:
Safety, tolerability and pharmacokinetic study of recombinant human parathyroid hormone [rhPTH (1-84)] in Chinese healthy volunteers

Cutler, D.L.; Tendolkar, A.; Grachev, I.D., 2013:
Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects

Kaste, M.; Murayama, S.; Ford, G.A.; Dippel, D.W.J.; Walters, M.R.; Tatlisumak, T., 2014:
Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen

Kumagai, Y.; Fujita, T.; Ozaki, M.; Yokota, S-ichi.; Maeda, M.; Shida, M.; Otani, Y.; Yamaya, H.; Tsuruta, H., 2009:
Safety, tolerability and pharmacokinetics of TAS-108, a novel anti-oestrogen, in healthy post-menopausal Japanese women: a phase I single oral dose study

van Hartingsveldt, B.; Nnane, I.P.; Bouman-Thio, E.; Loza, M.J.; Piantone, A.; Davis, H.M.; Petty, K.J., 2013:
Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study

Vachiery, J-Luc.; Huez, S.; Gillies, H.; Layton, G.; Hayashi, N.; Gao, X.; Naeije, R., 2011:
Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension

Derks, M.; Anzures-Cabrera, J.; Turnbull, L.; Phelan, M., 2011:
Safety, tolerability and pharmacokinetics of dalcetrapib following single and multiple ascending doses in healthy subjects: a randomized, double-blind, placebo-controlled, phase I study

Frey Tirri, B.; Bitzer, J.; Geudelin, B.; Drewe, J., 2011:
Safety, tolerability and pharmacokinetics of intravaginal pentamycin

Weller, S.; Jones, L.S.; Lou, Y.; Piscitelli, S.; Peppercorn, A.; Ng-Cashin, J., 2015:
Safety, tolerability and pharmacokinetics of orally inhaled zanamivir: a randomized study comparing Rotacap/Rotahaler and Rotadisk/Diskhaler in healthy adults

Zhao, L.; Yang, X.; Xu, R.; Wu, J.; Gu, S.; Zhang, L.; Gong, P.; Chen, H.; Zeng, F., 2009:
Safety, tolerability and pharmacokinetics of phenoprolamine hydrochloride floating sustained-release tablets in healthy Chinese subjects

Pascoe, S.; Reynolds, C.; Pleskow, W.; Perry, S.; Hmissi, A.; Kaiser, G.; Brookman, L., 2011:
Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD

Peeters, P.A.M.; van den Heuvel, M.W.; van Heumen, E.; Passier, P.C.C.M.; Smeets, J.M.W.; van Iersel, T.; Zwiers, A., 2010:
Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study

Othman, A.A.; Haig, G.; Florian, H.; Locke, C.; Zhang, J.; Dutta, S., 2013:
Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers

Paquette, J-Michel.; Rufiange, M.; Iovu Niculita, M.; Massicotte, J.; Lefebvre, M.; Colin, P.; Telmat, A.; Ranger, M., 2016 :
Safety, tolerability and pharmacokinetics of trimebutine 3-thiocarbamoylbenzenesulfonate (GIC-1001) in a randomized phase I integrated design study: single and multiple ascending doses and effect of food in healthy volunteers

Granel, B.; Daumas, Aélie.; Jouve, E.; Harlé, J-Robert.; Nguyen, P-Sébastien.; Chabannon, C.; Colavolpe, N.; Reynier, J-Charles.; Truillet, R.; Mallet, Séphanie.; Baiada, A.; Casanova, D.; Giraudo, L.; Arnaud, L.; Veran, J.; Sabatier, F.; Magalon, G., 2016:
Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial

Chistyakov, A.V.; Rubicsek, O.; Kaplan, B.; Zaaroor, M.; Klein, E., 2010:
Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression

Oba, Y.; Zaza, T.; Thameem, D.M., 2009:
Safety, tolerability and risk benefit analysis of tiotropium in COPD

Gonçalves, A.Katherine.; Cobucci, R.Ney.; Rodrigues, H.Marcus.; de Melo, A.Gosson.; Giraldo, P.César., 2015:
Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review

Siegel, M.; Garber, M.E.; Spencer, A.G.; Botwick, W.; Kumar, P.; Williams, R.N.; Kozuka, K.; Shreeniwas, R.; Pratha, V.; Adelman, D.C., 2012:
Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials

Winblad, B.; Andreasen, N.; Minthon, L.; Floesser, A.; Imbert, G.; Dumortier, T.; Maguire, R.Paul.; Blennow, K.; Lundmark, J.; Staufenbiel, M.; Orgogozo, J-Marc.; Graf, A., 2012:
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Alfaro, V.Y.; Goldblatt, D.L.; Valverde, G.R.; Munsell, M.F.; Quinton, L.J.; Walker, A.K.; Dantzer, R.; Varadhachary, A.; Scott, B.L.; Evans, S.E.; Tuvim, M.J.; Dickey, B.F., 2014:
Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands

Parry, G.J.; Rodrigues, C.M.P.; Aranha, M.M.; Hilbert, S.J.; Davey, C.; Kelkar, P.; Low, W.C.; Steer, C.J., 2010:
Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis

Karp, J.F.; Butters, M.A.; Begley, A.E.; Miller, M.D.; Lenze, E.J.; Blumberger, D.M.; Mulsant, B.H.; Reynolds, C.F., 2014:
Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults

Mease, P.J.; Wei, N.; Fudman, E.J.; Kivitz, A.J.; Schechtman, J.; Trapp, R.G.; Hobbs, K.F.; Greenwald, M.; Hou, A.; Bookbinder, S.A.; Graham, G.E.; Wiesenhutter, C.W.; Willis, L.; Ruderman, E.M.; Forstot, J.Z.; Maricic, M.J.; Dao, K.H.; Pritchard, C.H.; Fiske, D.N.; Burch, F.X.; Prupas, H.Malin.; Anklesaria, P.; Heald, A.E., 2010:
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study

Kunde, S.; Pham, A.; Bonczyk, S.; Crumb, T.; Duba, M.; Conrad, H.; Cloney, D.; Kugathasan, S., 2014:
Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis

Czömpöly, Tás.; Langmár, Zán.; Bors, Mária.; Zsákai, C.; Géczy, Mária.; Kulcsár, G., 2014:
Safety, tolerability, and effect on quality of life of a mixture of amino acids and other small molecules in cancer patients

Hadley, D.; Anderson, B.S.; Borckardt, J.J.; Arana, A.; Li, X.; Nahas, Z.; George, M.S., 2011:
Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting

Corey, R.; Naderer, O.J.; O'Riordan, W.D.; Dumont, E.; Jones, L.S.; Kurtinecz, M.; Zhu, J.Z., 2015:
Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections

Hicks, C.; Clay, P.; Redfield, R.; Lalezari, J.; Liporace, R.; Schneider, S.; Sension, M.; McRae, M.; Laurent, J-Pierre., 2013 :
Safety, tolerability, and efficacy of KP-1461 as monotherapy for 124 days in antiretroviral-experienced, HIV type 1-infected subjects

Bramlage, P.; Zemmrich, C.; Ketelhut, R.; Wolf, W-Peter.; Fronk, E-Maria.; Schmieder, R.E., 2014:
Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice

Rachlis, A.; Clotet, B.; Baxter, J.; Murphy, R.; Lefebvre, E., 2007:
Safety, tolerability, and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced, hepatitis B or C co-infected patients in POWER 1 and 3

Greenwald, B.D.; Dumot, J.A.; Horwhat, J.David.; Lightdale, C.J.; Abrams, J.A., 2010:
Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus

Bell, N.P.; Ramos, Jé.L.; Feldman, R.M., 2010:
Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension

Yuan, N.; Kane, P.; Shelton, K.; Matel, J.; Becker, B.C.; Moss, R.B., 2010:
Safety, tolerability, and efficacy of high-frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial

Hajjaji, I.; Shah, S.; Li, Y.; Prusty, V.; Benabbas, Y.; Home, P.D., 2014:
Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve study

Findling, R.L.; Pathak, S.; Earley, W.R.; Liu, S.; DelBello, M., 2014:
Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study

Squires, K.E.; Bekker, L-Gail.; Eron, J.J.; Cheng, B.; Rockstroh, J.K.; Marquez, F.; Kumar, P.; Thompson, M.; Campo, R.E.; Mounzer, K.; Strohmaier, K.M.; Lu, C.; Rodgers, A.; Jackson, B.E.; Wenning, L.A.; Robertson, M.; Nguyen, B-Yen.T.; Sklar, P.; Grinstejn, B.; Martins Netto, E.; Donastorg, Y.; Figueroa, P.; Botes, M.; Miller, S.; Barker, D.; Bedimo, R.; Campo, R.; Casey, K.; Cook, P.; Rieg, G.; Daar, E.; DeJesus, E.; Gathe, J.; Gilliam, B.; Gupta, S.; Goldman, M.; Hagins, D.; Hao, R.; Kadleci, 2013:
Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study

Alam, M.Y.; Jacobsen, P.L.; Chen, Y.; Serenko, M.; Mahableshwarkar, A.R., 2014:
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Yoshikawa, K.; Nakazawa, Y.; Katsuyama, Y.; Hirabayashi, K.; Saito, S.; Shigemura, T.; Tanaka, M.; Yanagisawa, R.; Sakashita, K.; Koike, K., 2015:
Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

Yoon, G.; Kim, S.Won.; Thuras, P.; Westermeyer, J., 2012:
Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study

Vermeulen, J.N.; Lange, J.M.A.; Tyring, S.K.; Peters, P.H.; Nunez, M.; Poland, G.; Levin, M.J.; Freeman, C.; Chalikonda, I.; Li, J.; Smith, J.G.; Caulfield, M.J.; Stek, J.E.; Chan, I.S.F.; Vessey, R.; Schödel, F.P.; Annunziato, P.W.; Schlienger, K.; Silber, J.L., 2012:
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age

Reisinger, K.S.; Block, S.L.; Collins-Ogle, M.; Marchant, C.; Catlett, M.; Radley, D.; Sings, H.L.; Haupt, R.M.; Garner, E.I.O., 2010:
Safety, tolerability, and immunogenicity of gardasil given concomitantly with Menactra and Adacel

Rodriguez, B.; Asmuth, D.M.; Matining, R.M.; Spritzler, J.; Jacobson, J.M.; Mailliard, R.B.; Li, X-Dong.; Martinez, A.I.; Tenorio, A.R.; Lori, F.; Lisziewicz, J.; Yesmin, S.; Rinaldo, C.R.; Pollard, R.B., 2013:
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial

Nell, A.S.; D'lom, E.; Bouic, P.; Sabaté, M.; Bosser, R.; Picas, J.; Amat, Mè.; Churchyard, G.; Cardona, P-Joan., 2015:
Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection

Mills, R.; Tyring, S.K.; Levin, M.J.; Parrino, J.; Li, X.; Coll, K.E.; Stek, J.E.; Schlienger, K.; Chan, I.S.F.; Silber, J.L., 2010:
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster

Wang, J.; Patil, S.P.; Yang, N.; Ko, J.; Lee, J.; Noone, S.; Sampson, H.A.; Li, X-Min., 2010:
Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study

Kieninger, D.M.; Kueper, K.; Steul, K.; Juergens, C.; Ahlers, N.; Baker, S.; Jansen, K.U.; Devlin, C.; Gruber, W.C.; Emini, E.A.; Scott, D.A.; Adelt, T.; Behre, U.; Blume, S.; Burow, H-Michael.; Büttner, H-Joanchim.; Clementsen, R.; Dehn, M.; Deigendesch, W.; Dietmair, E.; Distel, D.; Ernst, R.; Freund, R.; Habash, T.; Hubmann, M.; Janssen, U.; Kandzora, J.; Kessler, K-Dieter.; Knapp, G.; Knecht, R.; Kohl, A.; Laakmann, K-Heinz.; Landendörfer, W.; Lauf, R.; Lautenbach, P.; Lenz, T.; Leonhardt,, 2010:
Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany

Rose, M.A.; Weigand, B.; Schubert, R.; Schulze, J.; Zielen, S., 2012:
Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma--a prospective open clinical trial

Asmuth, D.M.; Murphy, R.L.; Rosenkranz, S.L.; Lertora, J.J.L.; Kottilil, S.; Cramer, Y.; Chan, E.S.; Schooley, R.T.; Rinaldo, C.R.; Thielman, N.; Li, X-Dong.; Wahl, S.M.; Shore, J.; Janik, J.; Lempicki, R.A.; Simpson, Y.; Pollard, R.B., 2010:
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial

Lowe, S.L.; Wong, C.J.; Witcher, J.; Gonzales, C.R.; Dickinson, G.L.; Bell, R.L.; Rorick-Kehn, L.; Weller, M.; Stoltz, R.R.; Royalty, J.; Tauscher-Wisniewski, S., 2015:
Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects

Dooley, K.E.; Park, J-Gun.; Swindells, S.; Allen, R.; Haas, D.W.; Cramer, Y.; Aweeka, F.; Wiggins, I.; Gupta, A.; Lizak, P.; Qasba, S.; van Heeswijk, R.; Flexner, C.; Sutherland, D.; Free, M.; Chicurel, M.; Tedder, C.W.; Koletar, S.L.; Harber, H.; Luetkemeyer, A.; Dwyer, J.; Hackman, J.; Weiss, A., 2012:
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267

Roberts, E.S.; Vanlare, K.A.; Strehlau, G.; Peyrou, M.; Roycroft, L.M.; King, S., 2014:
Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats

Bozik, M.E.; Mather, J.L.; Kramer, W.G.; Gribkoff, V.K.; Ingersoll, E.W., 2011:
Safety, tolerability, and pharmacokinetics of KNS-760704 (dexpramipexole) in healthy adult subjects

Ginsberg, A.M.; Laurenzi, M.W.; Rouse, D.J.; Whitney, K.D.; Spigelman, M.K., 2009:
Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects

O'Loughlin, J.; Millwood, I.Y.; McDonald, H.M.; Price, C.F.; Kaldor, J.M.; Paull, J.R.A., 2010:
Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study

Li, M.; Shi, A.; Pang, H.; Xue, W.; Li, Y.; Cao, G.; Yan, B.; Dong, F.; Li, K.; Xiao, W.; He, G.; Du, G.; Hu, X., 2015:
Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects

Dietrich, H.; Hu, K.; Ruffin, M.; Song, D.; Bouillaud, E.; Wang, Y.; Hasskarl, J., 2012:
Safety, tolerability, and pharmacokinetics of a single dose of pasireotide long-acting release in healthy volunteers: a single-center Phase I study

Choy, G.; Joshi-Hangal, R.; Oganesian, A.; Fine, G.; Rasmussen, S.; Collier, J.; Kissling, J.; Sahai, A.; Azab, M.; Redkar, S., 2012 :
Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers

Peterschmitt, M.Judith.; Burke, A.; Blankstein, L.; Smith, S.E.; Puga, A.Cristina.; Kramer, W.G.; Harris, J.A.; Mathews, D.; Bonate, P.L., 2011:
Safety, tolerability, and pharmacokinetics of eliglustat tartrate (Genz-112638) after single doses, multiple doses, and food in healthy volunteers

Nunes, T.; Rocha, Jé.F.; Vaz-da-Silva, M.; Igreja, B.; Wright, L.C.; Falcão, Aílcar.; Almeida, L.; Soares-da-Silva, P., 2011:
Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-β-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects

Cao, G-Ying.; Zhang, J.; Zhang, Y-Yuan.; Guo, B-Ning.; Yu, J-Cheng.; Wu, X-Jie.; Chen, Y-Cheng.; Wu, J-Fang.; Shi, Y-Guo., 2015:
Safety, tolerability, and pharmacokinetics of intravenous nemonoxacin in healthy chinese volunteers

Brennan, B.J.; Davies, B.; Cirrincione-Dall, G.; Morcos, P.N.; Beryozkina, A.; Chappey, C.; Aceves Baldó, P.; Lennon-Chrimes, S.; Rayner, C.R., 2013:
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteers

Karhu, D.; Gossen, E.R.; Mostert, A.; Cronjé, T.; Fradette, C., 2012:
Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects

Mann, D.; Liu, J.; Chew, M.L.; Bockbrader, H.; Alvey, C.W.; Zegarac, E.; Pellock, J.; Pitman, V.W., 2015:
Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled study

Brennan, B.J.; Wang, K.; Blotner, S.; Magnusson, M.O.; Wilkins, J.J.; Martin, P.; Solsky, J.; Nieforth, K.; Wat, C.; Grippo, J.F., 2014:
Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment

Dooley, K.E.; Sayre, P.; Borland, J.; Purdy, E.; Chen, S.; Song, I.; Peppercorn, A.; Everts, S.; Piscitelli, S.; Flexner, C., 2013:
Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects

Haluska, P.; Worden, F.; Olmos, D.; Yin, D.; Schteingart, D.; Batzel, G.N.; Paccagnella, M.Luisa.; de Bono, J.S.; Gualberto, A.; Hammer, G.D., 2010:
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

Uhl, W.; Zühlsdorf, M.; Koernicke, T.; Forssmann, U.; Kovar, A., 2014:
Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses

Konstan, M.W.; Sharma, A.; Moroni-Zentgraf, P.; Wang, F.; Koker, P., 2016:
Safety, tolerability, and plasma exposure of tiotropium Respimat® in children and adults with cystic fibrosis

Montaner, J.; Yeni, P.; Clumeck, N.N.; Fätkenheuer, G.; Gatell, J.; Hay, P.; Seminari, E.; Peeters, M.P.; Schöller-Gyüre, M.; Simonts, M.; Woodfall, B., 2008:
Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection

Meini, M.; Moncini, M.; Cecconi, D.; Cellesi, V.; Biasci, L.; Simoni, G.; Ameglio, M.; Pellegrini, M.; Forgione, R.N.; Rucci, P., 2011:
Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study

Mooney, J.J.; Pagel, P.S.; Kundu, A., 2015:
Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: a preliminary report

Nel, A.M.; Coplan, P.; van de Wijgert, J.H.; Kapiga, S.H.; von Mollendorf, C.; Geubbels, E.; Vyankandondera, J.; Rees, H.V.; Masenga, G.; Kiwelu, I.; Moyes, J.; Smythe, S.C., 2009:
Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women

Bush, M.A.; Matthews, J.E.; De Boever, E.H.; Dobbins, R.L.; Hodge, R.J.; Walker, S.E.; Holland, M.C.; Gutierrez, M.; Stewart, M.W., 2010:
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects

Kelleher, D.L.; Mehta, R.S.; Jean-Francois, B.M.; Preece, A.F.; Blowers, J.; Crater, G.D.; Thomas, P., 2013:
Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial

Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; Gansert, J., 2014:
Safety, tolerability, pharmacokinetics and antitumor activity of ganitumab, an investigational fully human monoclonal antibody to insulin-like growth factor type 1 receptor, combined with gemcitabine as first-line therapy in patients with metastatic pancreatic cancer: a phase 1b study

Seino, Y.; Nakajima, H.; Miyahara, H.; Kurita, T.; Bush, M.A.; Yang, F.; Stewart, M.W., 2010:
Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

Choy, E.H.; Bendit, M.; McAleer, D.; Liu, F.; Feeney, M.; Brett, S.; Zamuner, S.; Campanile, A.; Toso, J., 2014:
Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti- oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials

Patat, A.; Parks, V.; Raje, S.; Plotka, A.; Chassard, D.; Le Coz, F., 2009:
Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects

Teng, R.; Butler, K., 2014:
Safety, tolerability, pharmacokinetics and pharmacodynamics of high single-ascending doses of ticagrelor in healthy volunteers

Barbour, A.M.; Sarov-Blat, L.; Cai, G.; Fossler, M.J.; Sprecher, D.L.; Graggaber, J.; McGeoch, A.T.; Maison, J.; Cheriyan, J., 2014:
Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers

Liu, Y.; Shi, S.; Wu, J.; Li, Z.; Zhou, X.; Zeng, F., 2015:
Safety, tolerability, pharmacokinetics and pharmacodynamics of recombinant human parathyroid hormone after single- and multiple-dose subcutaneous administration in healthy Chinese volunteers

Sarashina, A.; Koiwai, K.; Seman, L.J.; Yamamura, N.; Taniguchi, A.; Negishi, T.; Sesoko, S.; Woerle, H.J.; Dugi, K.A., 2014:
Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects

Boss, D.S.; Schwartz, G.K.; Middleton, M.R.; Amakye, D.D.; Swaisland, H.; Midgley, R.S.; Ranson, M.; Danson, S.; Calvert, H.; Plummer, R.; Morris, C.; Carvajal, R.D.; Chirieac, L.R.; Schellens, J.H.M.; Shapiro, G.I., 2010:
Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours

Galasko, D.R.; Graff-Radford, N.; May, S.; Hendrix, S.; Cottrell, B.A.; Sagi, S.A.; Mather, G.; Laughlin, M.; Zavitz, K.H.; Swabb, E.; Golde, T.E.; Murphy, M.P.; Koo, E.H., 2007:
Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals

Wilfret, D.A.; Walker, J.; Adkison, K.K.; Jones, L.A.; Lou, Y.; Gan, J.; Castellino, S.; Moseley, C.L.; Horton, J.; de Serres, M.; Culp, A.; Goljer, I.; Spreen, W., 2014:
Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1

Petersen, K.L.; Iyengar, S.; Chappell, A.S.; Lobo, E.D.; Reda, H.; Prucka, W.R.; Verfaille, S.J., 2014:
Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers

Abarca, K.; Jung, E.; Fernández, P.; Zhao, L.; Harris, B.; Connor, E.M.; Losonsky, G.A., 2009:
Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children

Naik, H.; Vakilynejad, M.; Wu, J.; Viswanathan, P.; Dote, N.; Higuchi, T.; Leifke, E., 2012:
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of the GPR40 agonist TAK-875: results from a double-blind, placebo-controlled single oral dose rising study in healthy volunteers

Wolin, E.M.; Hu, K.; Hughes, G.; Bouillaud, E.; Giannone, V.; Resendiz, K.Hermosillo., 2013:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study

Iwamoto, K.; Nasu, R.; Yamamura, A.; Kothare, P.A.; Mace, K.; Wolka, A.M.; Linnebjerg, H., 2010:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetes

Chi, Y.Ha.; Lee, H.; Paik, S.Heui.; Lee, J.Han.; Yoo, B.Wook.; Kim, J.Han.; Tan, H.Kwang.; Kim, S.Lin., 2012:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects

Yamahira, N.; Frost, C.; Fukase, H.; Yu, Z.; Wang, J.; Pursley, J.; LaCreta, F.; Hiraoka, M., 2014:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects

Liu, Y.; Yang, C.; Li, Z.; Zhou, J.; Lv, Y.; Zhang, Y.; Zeng, F.; Shi, S., 2016:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant human parathyroid hormone (1-34) in healthy Chinese subjects

Hüttner, S.; Graefe-Mody, E.U.; Withopf, B.; Ring, A.; Dugi, K.A., 2008:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of BI 1356, an inhibitor of dipeptidyl peptidase 4, in healthy male volunteers

Mistry, P.; Reid, J.; Pouliquen, I.; McHugh, S.; Abberley, L.; DeWall, S.; Taylor, A.; Tong, X.; Rocha Del Cura, M.; McKie, E., 2016:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects

Yu, Y.; Logovinsky, V.; Schuck, E.; Kaplow, J.; Chang, M-Kun.; Miyagawa, T.; Wong, N.; Ferry, J., 2015:
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects

Boumans, M.J.H.; Houbiers, J.G.A.; Verschueren, P.; Ishikura, H.; Westhovens, R.; Brouwer, E.; Rojkovich, B.; Kelly, S.; den Adel, M.; Isaacs, J.; Jacobs, H.; Gomez-Reino, J.; Holtkamp, G.M.; Hastings, A.; Gerlag, D.M.; Tak, P.P., 2012:
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study

Trottier, S.; Omar, R.F.; Désormeaux, Aé.; Drouin, J.; Gagnon, M-Thérèse.; Vezina, F.; Guilbert, E.; Mâsse, Bît.; Bergeron, M.G., 2007:
Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners

Kolve, H.; Ahlke, E.; Fegeler, W.; Ritter, Jörg.; Jürgens, H.; Groll, A.H., 2009:
Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation

Nash, M.S.; Lewis, J.E.; Dyson-Hudson, T.A.; Szlachcic, Y.; Yee, F.; Mendez, A.J.; Spungen, A.M.; Bauman, W.A., 2011:
Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial

van Roosmalen, L.; Ritchie Orton, N.; Schneider, L., 2014:
Safety, usability, and independence for wheelchair-seated drivers and front-row passengers of private vehicles: a qualitative research study

Wang, Y.; Chen, S., 2014:
Safety-aware semi-supervised classification

Pal, A.; Labuza, T.P.; Diez-Gonzalez, F., 2009:
Safety-based shelf life model for frankfurters based on time to detect Listeria monocytogenes with initial inoculum below detection limit

Masket, S.; Fram, N.R., 2014:
Safety-basket suture for management of malpositioned posterior chamber intraocular lens

Jagger, J.; Perry, J., 2014:
Safety-engineered devices in 2012: the critical role of healthcare workers in device selection

Adams, D.; Elliott, T.S.J., 2012:
Safety-engineered needle devices: evaluation prior to introduction is essential

Touchette, D.R.; Masica, A.L.; Dolor, R.J.; Schumock, G.T.; Choi, Y.Ku.; Kim, Y.; Smith, S.R., 2013:
Safety-focused medication therapy management: a randomized controlled trial

Virgo, K.S.; Little, A.G.; Fedewa, S.A.; Chen, A.Y.; Flanders, W.Dana.; Ward, E.M., 2011:
Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer

Jackson, B.E.; Suzuki, S.; Coultas, D.; Su, F.; Lingineni, R.; Singh, K.P.; Bartolucci, A.; Bae, S., 2012:
Safety-net facilities and hospitalization rates of chronic obstructive pulmonary disease: a cross-sectional analysis of the 2007 Texas Health Care Information Council inpatient data

Zwanziger, J.; Khan, N., 2008:
Safety-net hospitals

Thompson, C.A., 2009:
Safety-net hospitals see more financial good than bad from Medicare Part D

Blum, J.D.; Conway, P.H.; VanLare, J.M., 2013 :
Safety-net hospitals: other hospitals score similarly on patient experience

Katz, M.H., 2011:
Safety-net providers and preparation for health reform: staff down, staff up, staff differently

Cunningham, P.; Felland, L.; Stark, L., 2013:
Safety-net providers in some US communities have increasingly embraced coordinated care models

Grimes, B., 2010:
Safety-net technology helps INTEGRIS Health reduce denials

Pelayo, S.; Hassler, S.; Bernonville, Séphanie.; Aldegheri, J.; Beuscart-Zephir, M-Catherine., 2014:
Safety-oriented usability test of a semi-automated unit dose system: role of task allocation between human and machine

Hamilton, E.S.B., 2018:
Safety-pin in larynx for five weeks

Tarantino, N.; Goodrum, N.; Armistead, L.P.; Cook, S.L.; Skinner, D.; Toefy, Y., 2016:
Safety-related moderators of a parent-based HIV prevention intervention in South Africa

Marino, M.; Frigo, F.; Bartolomeoli, I.; Maifreni, M., 2011:
Safety-related properties of staphylococci isolated from food and food environments

Giezen, T.J.; Mantel-Teeuwisse, A.K.; Straus, S.M.J.M.; Schellekens, H.; Leufkens, H.G.M.; Egberts, A.C.G., 2008:
Safety-related regulatory actions for biologicals approved in the United States and the European Union

Heemstra, H.E.; Giezen, T.J.; Mantel-Teeuwisse, A.K.; de Vrueh, R.L.A.; Leufkens, H.G.M., 2010:
Safety-related regulatory actions for orphan drugs in the US and EU: a cohort study

Hedtke, K.A.; Kendall, P.C.; Tiwari, S., 2009:
Safety-seeking and coping behavior during exposure tasks with anxious youth

Chaix, Jéphine.; Ma, E.; Nguyen, A.; Ortiz Collado, M.Assumpta.; Rexhaj, S.; Favrod, Jérôme., 2015:
Safety-seeking behaviours and verbal auditory hallucinations in schizophrenia

Pound, R., 2012:
Safety. Create a stronger voice for change

Szabo, J., 2010:
Safety. Study: keys to reducing needlestick injuries for residents

Chiu, P-Yi.; Dai, D-En.; Hsu, H-Pei.; Lee, C.; Lin, J-Jueng.; Kuo, H-Chou.; Huang, Y-Chih.; Liu, Y-Chang.; Tsai, C-Piao., 2010:
Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study

Bartus, R.T.; Baumann, T.L.; Siffert, J.; Herzog, C.D.; Alterman, R.; Boulis, N.; Turner, D.A.; Stacy, M.; Lang, A.E.; Lozano, A.M.; Olanow, C.Warren., 2013:
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients

Andris, D.A., 2012:
Safety: Not just a "buzzword" but an "action word" for A.S.P.E.N

Eisenhart, C., 1966:
Safety: a parallel

Kirchner, B., 2009:
Safety: addressing inappropriate behavior in the perioperative workplace

Currie, L., 2011:
Safety: principle of nursing practice C

Stichler, J.F., 2012:
Safety: priority no. 1

Hill, J., 2009:
Safety: protecting yourself should be your #1 priority

Bowers, L., 2015:
Safewards: a new model of conflict and containment on psychiatric wards

Bowers, L.; Alexander, J.; Bilgin, H.; Botha, M.; Dack, C.; James, K.; Jarrett, M.; Jeffery, D.; Nijman, H.; Owiti, J.A.; Papadopoulos, C.; Ross, J.; Wright, S.; Stewart, D., 2015:
Safewards: the empirical basis of the model and a critical appraisal

He, J.; Yang, Y-Nan.; Jiang, J-Shuang.; Feng, Z-Ming.; Zhang, P-Cheng., 2015:
Saffloflavonesides A and B, two rearranged derivatives of flavonoid C-glycosides with a furan-tetrahydrofuran ring from Carthamus tinctorius

Park, J.B.; Wang, T.T.Y., 2012:
Safflomide increases the expression of adiponectin in vitro and in vivo: potential implication for hypoadiponectemia, visceral obesity, and insulin resistance

Wang, C.; He, Y.; Yang, M.; Sun, H.; Zhang, S.; Wang, C., 2014:
Safflor yellow B suppresses angiotensin II-mediated human umbilical vein cell injury via regulation of Bcl-2/p22(phox) expression

Wang, C.; Ma, H.; Zhang, S.; Wang, Y.; Liu, J.; Xiao, X., 2009:
Safflor yellow B suppresses pheochromocytoma cell (PC12) injury induced by oxidative stress via antioxidant system and Bcl-2 /Bax pathway

Yang, H.; Downs, R.T.; Eichler, C., 2008:
Safflorite, (Co,Ni,Fe)As(2), isomorphous with marcasite

Higa, R.; White, V.; Martínez, N.; Kurtz, M.; Capobianco, E.; Jawerbaum, A., 2010:
Safflower and olive oil dietary treatments rescue aberrant embryonic arachidonic acid and nitric oxide metabolism and prevent diabetic embryopathy in rats

Zhao, G.; Zheng, X-Wei.; Gai, Y.; Chu, W-Jing.; Qin, G-Wei.; Guo, L-He., 2009:
Safflower extracts functionally regulate monoamine transporters

Fan, S.; Lin, N.; Shan, G.; Zuo, P.; Cui, L., 2015:
Safflower yellow for acute ischemic stroke: A systematic review of randomized controlled trials

Liu, Y.; Tian, X.; Cui, M.; Zhao, S., 2015:
Safflower yellow inhibits angiotensin II-induced adventitial fibroblast proliferation and migration

Kong, D.; Xia, W.; Zhang, Z.; Xiao, L.; Yuan, D.; Liu, Y.; Yang, G., 2014:
Safflower yellow injection combined with conventional therapy in treating unstable angina pectoris: a meta-analysis

Mora, S.; Manna, M., 2009:
Saffman-Taylor instability for generalized Newtonian fluids

Mora, S.; Manna, M., 2010:
Saffman-Taylor instability of viscoelastic fluids: from viscous fingering to elastic fractures

Luque, A.; Brau, F.; Ebert, U., 2008:
Saffman-Taylor streamers: mutual finger interaction in spark formation

Galama, J.M.D.; Zoll, J.G.; Lanke, K.H.; de Jong, A.S.; Melief, J.; Huitinga, I.; Verbeek, M.M.; van Kuppeveld, F.J.M., 2014:
Saffold cardiovirus and multiple sclerosis: no evidence for an association

Ren, L.; Gonzalez, R.; Xiao, Y.; Xu, X.; Chen, L.; Vernet, G.; Paranhos-Baccala, G.; Jin, Q.; Wang, J., 2010:
Saffold cardiovirus in children with acute gastroenteritis, Beijing, China

Itagaki, T.; Abiko, C.; Aoki, Y.; Ikeda, T.; Mizuta, K.; Noda, M.; Kimura, H.; Matsuzaki, Y., 2011:
Saffold cardiovirus infection in children associated with respiratory disease and its similarity to coxsackievirus infection

Khamrin, P.; Chaimongkol, N.; Nantachit, N.; Okitsu, S.; Ushijima, H.; Maneekarn, N., 2011:
Saffold cardioviruses in children with diarrhea, Thailand

Ren, L.; Gonzalez, R.; Xie, Z.; Xiao, Y.; Li, Y.; Liu, C.; Chen, L.; Yang, Q.; Vernet, G.; Paranhos-Baccalà, G.; Jin, Q.; Shen, K.; Wang, J., 2010:
Saffold cardioviruses of 3 lineages in children with respiratory tract infections, Beijing, China

Chua, K.Bing.; Voon, K.; Yu, M.; Ali, W.Nor.Azlina.Wan.; Kasri, A.Rasid.; Wang, L-Fa., 2011:
Saffold virus infection in children, Malaysia, 2009

Himeda, T.; Hosomi, T.; Okuwa, T.; Muraki, Y.; Ohara, Y., 2013:
Saffold virus type 3 (SAFV-3) persists in HeLa cells

Zoll, J.; Erkens Hulshof, S.; Lanke, K.; Verduyn Lunel, F.; Melchers, W.J.G.; Schoondermark-van de Ven, E.; Roivainen, M.; Galama, J.M.D.; van Kuppeveld, F.J.M., 2009:
Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life

Hausenblas, H.Ann.; Saha, D.; Dubyak, P.Jean.; Anton, S.Douglas., 2014:
Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials

Bajerska, J.; Mildner-Szkudlarz, S.; Podgórski, T.; Oszmatek-Pruszyńska, E., 2014:
Saffron (Crocus sativus L.) powder as an ingredient of rye bread: an anti-diabetic evaluation

Ghoshooni, H.; Daryaafzoon, M.; Sadeghi-Gharjehdagi, S.; Zardooz, H.; Sahraei, H.; Tehrani, S.P.; Noroozzadeh, A.; Bahrami-Shenasfandi, F.; Kaka, G.H.; Sadraei, S.H., 2012:
Saffron (Crocus sativus) ethanolic extract and its constituent, safranal, inhibits morphine-induced place preference in mice

Lopresti, A.L.; Drummond, P.D., 2015:
Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action

Bathaie, S.Zahra.; Miri, H.; Mohagheghi, M-Ali.; Mokhtari-Dizaji, M.; Shahbazfar, A-Ali.; Hasanzadeh, H., 2013:
Saffron Aqueous Extract Inhibits the Chemically-induced Gastric Cancer Progression in the Wistar Albino Rat

Makri, O.E.; Ferlemi, A-Varvara.; Lamari, F.N.; Georgakopoulos, C.D., 2013:
Saffron administration prevents selenite-induced cataractogenesis

Bolhassani, A.; Khavari, A.; Bathaie, S.Zahra., 2014:
Saffron and natural carotenoids: Biochemical activities and anti-tumor effects

Bisti, S.; Maccarone, R.; Falsini, B., 2015:
Saffron and retina: neuroprotection and pharmacokinetics

Geromichalos, G.D.; Lamari, F.N.; Papandreou, M.A.; Trafalis, D.T.; Margarity, M.; Papageorgiou, A.; Sinakos, Z., 2012:
Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies

Berger, F.; Hensel, A.; Nieber, K., 2011:
Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices

Kashani, L.; Raisi, F.; Saroukhani, S.; Sohrabi, H.; Modabbernia, A.; Nasehi, A-Ali.; Jamshidi, A.; Ashrafi, M.; Mansouri, P.; Ghaeli, P.; Akhondzadeh, S., 2013:
Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study

Asadi, M.Hossein.; Zafari, F.; Sarveazad, A.; Abbasi, M.; Safa, M.; Koruji, M.; Yari, A.; Alizadeh Miran, R., 2014:
Saffron improves epididymal sperm parameters in rats exposed to cadmium

Shemshian, M.; Mousavi, S.Hadi.; Norouzy, A.; Kermani, T.; Moghiman, T.; Sadeghi, A.; Ghayour-Mobarhan, M.; Ferns, G.A., 2014:
Saffron in metabolic syndrome: its effects on antibody titers to heat-shock proteins 27, 60, 65 and 70

Schmidt, M.; Betti, G.; Hensel, A., 2007:
Saffron in phytotherapy: pharmacology and clinical uses

Akhondzadeh, S.; Sabet, M.Shafiee.; Harirchian, M.H.; Togha, M.; Cheraghmakani, H.; Razeghi, S.; Hejazi, S.Sh.; Yousefi, M.H.; Alimardani, R.; Jamshidi, A.; Zare, F.; Moradi, A., 2011:
Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial

Rubio-Moraga, A.; Castillo-López, R.; Gómez-Gómez, L.; Ahrazem, O., 2009:
Saffron is a monomorphic species as revealed by RAPD, ISSR and microsatellite analyses

Purushothuman, S.; Nandasena, C.; Peoples, C.L.; El Massri, N.; Johnstone, D.M.; Mitrofanis, J.; Stone, J., 2014:
Saffron pre-treatment offers neuroprotection to Nigral and retinal dopaminergic cells of MPTP-Treated mice

Ziaee, T.; Razavi, B.Marjan.; Hosseinzadeh, H., 2014:
Saffron reduced toxic effects of its constituent, safranal, in acute and subacute toxicities in rats

Manoharan, S.; Wani, S.Afaq.; Vasudevan, K.; Manimaran, A.; Prabhakar, M.Manoj.; Karthikeyan, S.; Rajasekaran, D., 2014:
Saffron reduction of 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis

Lech, K.; Witowska-Jarosz, J.; Jarosz, M., 2010:
Saffron yellow: characterization of carotenoids by high performance liquid chromatography with electrospray mass spectrometric detection

Modabbernia, A.; Akhondzadeh, S., 2013:
Saffron, passionflower, valerian and sage for mental health

Hosseinzadeh, H., 2014:
Saffron: a herbal medicine of third millennium

Amin, A.; Hamza, A.A.; Bajbouj, K.; Ashraf, S.Salman.; Daoud, S., 2012:
Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma

Kandadai, R.Mridula.; Jabeen, S.Afshan.; Kanikannan, M.A.; Borgohain, R., 2015:
Safinamide for the treatment of Parkinson's disease

Chazot, P.L., 2007:
Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome

Schapira, A.H.V., 2011:
Safinamide in the treatment of Parkinson's disease

Coward, J.; Ambrosini, G.; Musi, E.; Truman, J-Philip.; Haimovitz-Friedman, A.; Allegood, J.C.; Wang, E.; Merrill, A.H.; Schwartz, G.K., 2009:
Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway

Samarghandian, S.; Borji, A.; Delkhosh, M.Bagher.; Samini, F., 2014:
Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats

Geromichalos, G.D.; Papadopoulos, T.; Sahpazidou, D.; Sinakos, Z., 2015 :
Safranal, a Crocus sativus L constituent suppresses the growth of K-562 cells of chronic myelogenous leukemia. In silico and in vitro study

Maeda, A.; Kai, K.; Ishii, M.; Ishii, T.; Akagawa, M., 2015:
Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice

Fernández-Sánchez, L.; Lax, P.; Esquiva, G.; Martín-Nieto, Jé.; Pinilla, I.; Cuenca, Nás., 2013:
Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats

Rezaee, R.; Hosseinzadeh, H., 2013:
Safranal: from an aromatic natural product to a rewarding pharmacological agent

Conn, H.J., 1923:
Safranin and Methyl Green

Lofrumento, C.; Arci, F.; Carlesi, S.; Ricci, M.; Castellucci, E.; Becucci, M., 2015:
Safranin-O dye in the ground state. A study by density functional theory, Raman, SERS and infrared spectroscopy

Perevoshchikova, I.V.; Sorochkina, A.I.; Zorov, D.B.; Antonenko, Y.N., 2009:
Safranine O as a fluorescent probe for mitochondrial membrane potential studied on the single particle level and in suspension

Figueira, T.R.; Melo, D.R.; Vercesi, Aíbal.E.; Castilho, R.F., 2012:
Safranine as a fluorescent probe for the evaluation of mitochondrial membrane potential in isolated organelles and permeabilized cells

Yu, C-Shu.; Huang, A-Cheng.; Yang, J-Sing.; Yu, C-Chih.; Lin, C-Chung.; Chung, H-Kwang.; Huang, Y-Ping.; Chueh, F-Shin.; Chung, J-Gung., 2012:
Safrole induces G0/G1 phase arrest via inhibition of cyclin E and provokes apoptosis through endoplasmic reticulum stress and mitochondrion-dependent pathways in human leukemia HL-60 cells

Yu, F-S.; Yang, J-S.; Yu, C-S.; Lu, C-C.; Chiang, J-H.; Lin, C-W.; Chung, J-G., 2011:
Safrole induces apoptosis in human oral cancer HSC-3 cells

Zhao, Y.; Xin, J.; Sun, C.; Zhao, B.; Zhao, J.; Su, L., 2012:
Safrole oxide induced neuronal differentiation of rat bone-marrow mesenchymal stem cells by elevating Hsp70

Su, L.; Zhang, H.; Zhao, J.; Zhang, S.; Zhang, Y.; Zhao, B.; Miao, J., 2013:
Safrole-2',3'-oxide induces atherosclerotic plaque vulnerability in apolipoprotein E-knockout mice

Chiang, S-yin.; Lee, P-yi.; Lai, M-tsung.; Shen, L-ching.; Chung, W-sheng.; Huang, H-fen.; Wu, K-yuh.; Wu, H-ching., 2012:
Safrole-2',3'-oxide induces cytotoxic and genotoxic effects in HepG2 cells and in mice

Fan, M-J.; Lin, S-Y.; Yu, C-C.; Tang, N-Y.; Ho, H-C.; Chung, H-K.; Yang, J-S.; Huang, Y-P.; Ip, S-W.; Chung, J-G., 2013:
Safrole-modulated immune response is mediated through enhancing the CD11b surface marker and stimulating the phagocytosis by macrophages in BALB/c mice

Xu, J-Ping.; Guo, W-Rong.; Lin, G-Bing., 2013:
Safty action of heat shock protein 27 in reperfusion after spinal marrow ischemia

Walsh, J., 1983:
Sag in the market for scientists, engineers

Hatakeyama, M., 2008:
SagA of CagA in Helicobacter pylori pathogenesis

Sun, Y.; Sun, L.; Xing, M-qing.; Liu, C-sheng.; Hu, Y-hua., 2015:
SagE induces highly effective protective immunity against Streptococcus iniae mainly through an immunogenic domain in the extracellular region

Petrova, O.E.; Sauer, K., 2012:
SagS contributes to the motile-sessile switch and acts in concert with BfiSR to enable Pseudomonas aeruginosa biofilm formation

Molvaer, O.Inge., 2009:
Saga about a cyst

Reinbach, H., 2018:
Saga of industrial nursing in Kansas

Manchikanti, L.; Singh, V.; Hirsch, J.A., 2012:
Saga of payment systems of ambulatory surgery centers for interventional techniques: an update

Morita, M.; Igarashi, Y.; Ito, M.; Chen, Y-An.; Nagao, C.; Sakaguchi, Y.; Sakate, R.; Masui, T.; Mizuguchi, K., 2013:
Sagace: a web-based search engine for biomedical databases in Japan

Nau, J-Yves.; Sagan, Fçoise.; Blondin, A., 2010:
Sagan (Françoise), Blondin, Palfium and writings

Waldrop, M.M., 1988:
Sagdeev to step down

Deeb, S.Joseph.; El-Baba, C.Omar.; Hassan, S.Bashir.; Larsson, R.Lennart.; Gali-Muhtasib, H.Uthman., 2011:
Sage components enhance cell death through nuclear factor kappa-B signaling

Marchev, A.; Haas, C.; Schulz, S.; Georgiev, V.; Steingroewer, J.; Bley, T.; Pavlov, A., 2014:
Sage in vitro cultures: a promising tool for the production of bioactive terpenes and phenolic substances

Goedert, J., 2007:
Sage sets its health I.T. table

Sá, C.M.; Ramos, A.A.; Azevedo, M.F.; Lima, C.F.; Fernandes-Ferreira, M.; Pereira-Wilson, C., 2009:
Sage tea drinking improves lipid profile and antioxidant defences in humans

Park, S-Hye.; Kim, J-Lye.; Kang, M-Kyung.; Gong, J-Hyun.; Han, S-Young.; Shim, J-Hoon.; Lim, S.Sung.; Kang, Y-Hee., 2013:
Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages

Cardon, Z.G.; Stark, J.M.; Herron, P.M.; Rasmussen, J.A., 2014:
Sagebrush carrying out hydraulic lift enhances surface soil nitrogen cycling and nitrogen uptake into inflorescences

Savoiardo, M.; Farina, L.; Chiapparini, L., 2010:
Sagging and swelling of the midbrain suggest spontaneous intracranial hypotension rather than a malformation

Huang, Y-Min.; Davidsson, L., 2013:
Sagging brain development after lumbar puncture agrees with Monro-Kellie hypothesis

Luna, J.; Khanna, I.; Cook, F.J.; Marti, E.M.; Hoppenot, R.G., 2015:
Sagging brain masquerading as a pituitary adenoma

Anonymous, 2011:
Sagging economy, reform drive hospital deals

Chaudhuri, Z.; Demer, J.L., 2013:
Sagging eye syndrome: connective tissue involution as a cause of horizontal and vertical strabismus in older patients

Espín, L.; Kumar, S., 2014:
Sagging of evaporating droplets of colloidal suspensions on inclined substrates

Ezure, T.; Hosoi, J.; Amano, S.; Tsuchiya, T., 2009 :
Sagging of the cheek is related to skin elasticity, fat mass and mimetic muscle function

Jeong, Y.Mi.; Shin, M.Jin.; Lee, S.Hoon.; Chung, H.Won., 2014:
Sagging posterior layer thoracolumbar fascia: can it be the cause or result of adjacent segment diseases?

Pimentel, G.D.; Moreto, F.; Takahashi, M.M.; Portero-McLellan, K.C.; Burini, R.C., 2012:
Sagital abdominal diameter, but not waist circumference is strongly associated with glycemia, triacilglycerols and HDL-C levels in overweight adults

Yu, Q.; Pan, X-gang.; Qian, Y-fen.; Fan, L-feng., 2015:
Sagital position of glenoid fossa in Angle Class II malocclusion with mandibular retrusion

Sasao, Y.; Kojima, A.; Torii, Y.; Morioka, S.; Fujii, A.; Aoki, H., 2018:
Sagittal Alignment of Spine and Spinal Cord for Upper Cervical Irreducible Atlantoaxial Kyphosis in Elderly Patients

Kasemeier-Kulesa, J.C.; Lefcort, F.; Kulesa, P.M., 2007:
Sagittal Explant Culture for 3D Confocal Time-Lapse Analysis of Chick Peripheral Nervous System Formation

Sakima, H.; Isa, K.; Goya, Y.; Ohya, Y., 2013:
Sagittal MR black blood imaging revealing ACA dissection

Padua, D.A.; Distefano, L.J., 2009:
Sagittal Plane Knee Biomechanics and Vertical Ground Reaction Forces Are Modified Following ACL Injury Prevention Programs: A Systematic Review

Karia, S.J.; Kassamali, R.H., 2012:
Sagittal T2 weighted magnetic resonance image of the lumbar spine

Gletsu-Miller, N.; Kahn, H.S.; Gasevic, D.; Liang, Z.; Frediani, J.K.; Torres, W.E.; Ziegler, T.R.; Phillips, L.S.; Lin, E., 2014:
Sagittal abdominal diameter and visceral adiposity: correlates of beta-cell function and dysglycemia in severely obese women

Vasques, A.Carolina.Junqueira.; Souza, Jé.Roberto.Matos.; Yamanaka, A.; de Oliveira, M.da.Saúde.; Novaes, F.Satake.; Pareja, Jé.Carlos.; Geloneze, B., 2013:
Sagittal abdominal diameter as a marker for epicardial adipose tissue in premenopausal women

Petersson, H.; Daryani, A.; Risérus, U., 2007:
Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study

Pajunen, P.; Rissanen, H.; Laaksonen, M.A.; Heliövaara, M.; Reunanen, A.; Knekt, P., 2013:
Sagittal abdominal diameter as a new predictor for incident diabetes

Risérus, U.; de Faire, U.; Berglund, L.; Hellénius, M-L., 2010:
Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk

Clerc, D.; Blaser, B.; Demartines, N.; Christoforidis, D., 2015:
Sagittal abdominal diameter is a better predictor than body mass index for duration of laparoscopic left colectomy

Dahlén, E.M.; Bjarnegård, N.; Länne, T.; Nystrom, F.H.; Ostgren, C.J., 2013:
Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes--a prospective observational cohort study

Yim, J.Yoon.; Kim, D.; Lim, S.Hee.; Park, M.Jeong.; Choi, S.Ho.; Lee, C.Hyun.; Kim, S.Sin.; Cho, S-Heon., 2011:
Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population

Lee, M.Jung.; Shin, D.Ho.; Kim, S.Jun.; Yoo, D.Eun.; Ko, K.Il.; Koo, H.Mo.; Kim, C.Ho.; Doh, F.Mee.; Oh, H.Jung.; Park, J.Tak.; Han, S.Hyeok.; Yoo, T-Hyun.; Choi, K.Hun.; Kang, S-Wook., 2014:
Sagittal abdominal diameter is an independent predictor of all-cause and cardiovascular mortality in incident peritoneal dialysis patients

Sasso, R.C.; Metcalf, N.H.; Hipp, J.A.; Wharton, N.D.; Anderson, P.A., 2011:
Sagittal alignment after Bryan cervical arthroplasty

Watkins, R.G.; Hanna, R.; Chang, D.; Watkins, R.G., 2014:
Sagittal alignment after lumbar interbody fusion: comparing anterior, lateral, and transforaminal approaches

Guérin, P.; Obeid, I.; Gille, O.; Bourghli, A.; Luc, Séphane.; Pointillart, V.; Vital, J-Marc., 2012:
Sagittal alignment after single cervical disc arthroplasty

Park, M.Soo.; Kelly, M.P.; Lee, D-Ho.; Min, W-Kie.; Rahman, R'Kerry.K.; Riew, K.Daniel., 2015:
Sagittal alignment as a predictor of clinical adjacent segment pathology requiring surgery after anterior cervical arthrodesis

Djurasovic, M.O.; Carreon, L.Y.; Glassman, S.D.; Dimar, J.R.; Puno, R.M.; Johnson, J.R., 2009:
Sagittal alignment as a risk factor for adjacent level degeneration: a case-control study

Aizawa, T.; Sato, T.; Ozawa, H.; Morozumi, N.; Matsumoto, F.; Sasaki, H.; Hoshikawa, T.; Kawahara, C.; Kokubun, S.; Itoi, E., 2008:
Sagittal alignment changes after thoracic laminectomy in adults

Yanbin, Z.; Yu, S.; Zhongqiang, C.; Zhongjun, L., 2011:
Sagittal alignment comparison of Bryan disc arthroplasty with ProDisc-C arthroplasty: a prospective, randomized controlled clinical trial

Berjano, P.; Damilano, M.; Lamartina, C., 2013:
Sagittal alignment correction and reconstruction of lumbar post-traumatic kyphosis via MIS lateral approach

Charles, Y.P.; Meyer, N.; Steib, J-P., 2008:
Sagittal alignment correction of the thoracolumbar junction in idiopathic scoliosis by in situ bending technique

Zhu, Z.; Xu, L.; Zhu, F.; Jiang, L.; Wang, Z.; Liu, Z.; Qian, B-ping.; Qiu, Y., 2014:
Sagittal alignment of spine and pelvis in asymptomatic adults: norms in Chinese populations

Ilharreborde, B.; Vidal, C.; Skalli, W.; Mazda, K., 2013:
Sagittal alignment of the cervical spine in adolescent idiopathic scoliosis treated by posteromedial translation

Terauchi, M.; Hatayama, K.; Yanagisawa, S.; Saito, K.; Takagishi, K., 2011:
Sagittal alignment of the knee and its relationship to noncontact anterior cruciate ligament injuries

Sugama, R.; Minoda, Y.; Kobayashi, A.; Iwaki, H.; Ikebuchi, M.; Hashimoto, Y.; Takaoka, K.; Nakamura, H., 2011:
Sagittal alignment of the lower extremity while standing in female

Sevinc, O.; Is, M.; Barut, C.; Ozdemir, S.T.; Ayoglu, F., 2007:
Sagittal alignment of the lumbar spine in a Turkish population

Mukai, Y.; Hosono, N.; Sakaura, H.; Fujii, R.; Iwasaki, M.; Fuchiya, T.; Fujiwara, K.; Fuji, T.; Yoshikawa, H., 2007:
Sagittal alignment of the subaxial cervical spine after C1-C2 transarticular screw fixation in rheumatoid arthritis

Levine, H.B.; Bosco, J.A., 2007:
Sagittal and coronal biomechanics of the knee: a rationale for corrective measures

Novak, A.C.; Brouwer, B., 2011:
Sagittal and frontal lower limb joint moments during stair ascent and descent in young and older adults

McMillan, A.G.; Pulver, A.M.E.; Collier, D.N.; Williams, D.S.B., 2010:
Sagittal and frontal plane joint mechanics throughout the stance phase of walking in adolescents who are obese

Estrada-Molina, A.; Campos-García, M.; Díaz-Uribe, R., 2013:
Sagittal and meridional radii of curvature for a surface with symmetry of revolution by using a null-screen testing method

Cabrera, L.de.Castro.; Retamoso, L.Borges.; Mei, R.Magnoler.Sampaio.; Tanaka, O., 2014:
Sagittal and vertical aspects of Class II division 1 subjects according to the respiratory pattern

Medawar, C., 2007:
Sagittal and vertical dentoalveolar compensation in hyperdivergent malocclusion: control using the Straight Wire Integrated In Normal Growth (SWING) system

Farronato, G.; Giannini, L.; Galbiati, G.; Maspero, C., 2011:
Sagittal and vertical effects of rapid maxillary expansion in Class I, II, and III occlusions

Crismani, A.G.; Celar, A.G.; Burstone, C.J.; Bernhart, T.G.; Bantleon, H-Peter.; Mittlboeck, M., 2007:
Sagittal and vertical load-deflection and permanent deformation of transpalatal arches connected with palatal implants: an in-vitro study

Bretos, J.Luis.Gonçalves.; Pereira, M.D.; Gomes, H.C.; Toyama Hino, C.; Ferreira, L.M., 2007:
Sagittal and vertical maxillary effects after surgically assisted rapid maxillary expansion (SARME) using Haas and Hyrax expanders

Wu, J.Yung.Chuan.; Hägg, U.; Pancherz, H.; Wong, R.Wing.Kit.; McGrath, C., 2010:
Sagittal and vertical occlusal cephalometric analyses of Pancherz: Norms for Chinese children

Denny, M.; McGowan, R.S., 2014:
Sagittal area of the vocal tract in young female children

Lippold, C.; Segatto, E.; Végh, Aás.; Drerup, B.; Moiseenko, T.; Danesh, G., 2010:
Sagittal back contour and craniofacial morphology in preadolescents

Lenke, L.G., 2014:
Sagittal balance

Baghdadi, Y.M.K.; Larson, A.Noelle.; Dekutoski, M.B.; Cui, Q.; Sebastian, A.S.; Armitage, B.M.; Nassr, A., 2014:
Sagittal balance and spinopelvic parameters after lateral lumbar interbody fusion for degenerative scoliosis: a case-control study

Charles, Y.Philippe.; Bouchaïb, J.; Walter, A.; Schuller, Sébastien.; Sauleau, E.André.; Steib, J-Paul., 2013:
Sagittal balance correction of idiopathic scoliosis using the in situ contouring technique

La Maida, G.Andrea.; Zottarelli, L.; Mineo, G.Vincenzo.; Misaggi, B., 2015:
Sagittal balance in adolescent idiopathic scoliosis: radiographic study of spino-pelvic compensation after surgery

Glard, Y.; Pomero, V.; Collignon, P.; Skalli, W.; Jouve, J-Luc.; Bollini, Gérard., 2009:
Sagittal balance in scoliosis associated with Marfan syndrome: a stereoradiographic three-dimensional analysis

Rabin, D.; Bertagnoli, R.; Wharton, N.; Pickett, G.E.; Duggal, N., 2008:
Sagittal balance influences range of motion: an in vivo study with the ProDisc-C

Faundez, A.; Roussouly, P.; Le Huec, J.C., 2012:
Sagittal balance of the spine: a therapeutic revolution

Aebi, M., 2012:
Sagittal balance of the spine: consequences for the treatment of the degenerative spine

Schmidt, C.; Liljenqvist, U.; Lerner, T.; Schulte, T.L.; Bullmann, V., 2012:
Sagittal balance of thoracic lordoscoliosis: anterior dual rod instrumentation versus posterior pedicle screw fixation

Villard, J.; Ringel, F.; Meyer, B., 2016:
Sagittal balance, a useful tool for neurosurgeons?

Anakwenze, O.A.; Auerbach, J.D.; Milby, A.H.; Lonner, B.S.; Balderston, R.A., 2009:
Sagittal cervical alignment after cervical disc arthroplasty and anterior cervical discectomy and fusion: results of a prospective, randomized, controlled trial

Letti, H.Carolina.Becker.; Rizzatto, S.Maria.Deon.; de Menezes, L.Macedo.; Reale, C.Sangalli.; de Lima, E.Martinelli.; Martinelli, F.Lima., 2014:
Sagittal changes in lower incisors by the use of lingual arch

Chen, X.; Wang, H.; Cai, Y.; Zhu, Q.; Zhu, J., 2015:
Sagittal component alignment is less reliable than coronal component alignment in a Chinese population undergoing navigated TKA

Luo, L.; Selvanathan, S.K., 2015:
Sagittal computed tomogram of the cervicothoracic spine

Gibson, L.Mary.; Blankenstein, T.Nicholas., 2014:
Sagittal computed tomogram of the neck with bone windows

Rostom, M., 2014:
Sagittal computed tomography angiogram of the abdomen with contrast

Saini, A.Kumar.; Afolayan, J., 2013:
Sagittal computed tomography of the ankle

Shelmerdine, S.Cheng., 2012:
Sagittal computed tomography of the sellar region

Harnet, J-Cl.; Lombardi, T.; Lutz, J-Ch.; Meyer, P.; Kahn, J-L., 2007:
Sagittal craniofacial growth evaluated on children dry skulls using V2 and V3 canal openings as references

Kaiser, G.Louis.; Oesch, Vérie., 2008:
Sagittal craniosynostosis combined with ossified cephalhematoma--a tricky and demanding puzzle

Nakahara, H.; Matsuda, S.; Okazaki, K.; Tashiro, Y.; Iwamoto, Y., 2013:
Sagittal cutting error changes femoral anteroposterior sizing in total knee arthroplasty

Lee, S-Hun.; Kim, K-Tack.; Suk, K-Soo.; Lee, J-Hee.; Seo, E-Min.; Huh, D-Seok., 2011:
Sagittal decompensation after corrective osteotomy for lumbar degenerative kyphosis: classification and risk factors

Diebo, B.G.; Henry, J.; Lafage, V.; Berjano, P., 2015:
Sagittal deformities of the spine: factors influencing the outcomes and complications

Akbar, M.; Wiedenhöfer, B., 2012:
Sagittal deformity. Basic principles of surgical strategies

Fang, J-hu.; Jia, L-shun.; Zhou, X-hui.; Chen, X-sheng.; Zhang, Y., 2009:
Sagittal diameters measurements on MR of the cervical spinal cord in normal subjects

Roach, J.M.; Pfau, T.; Bryars, J.; Unt, V.; Channon, S.B.; Weller, R., 2015:
Sagittal distal limb kinematics inside the hoof capsule captured using high-speed fluoroscopy in walking and trotting horses

Kaya Bicer, E.; Servien, E.; Lustig, S.; Demey, G.; Ait Si Selmi, T.; Neyret, P., 2010:
Sagittal flexion angle of the femoral component in unicompartmental knee arthroplasty: is it same for both medial and lateral UKAs?

Nisawa, A.; Yoneda, Y.; Ueno, G.; Murakami, H.; Okajima, Y.; Yamamoto, K.; Senba, Y.; Uesugi, K.; Tanaka, Y.; Yamamoto, M.; Goto, S.; Ishikawa, T., 2013:
Sagittal focusing of synchrotron radiation X-rays using a winged crystal

Hananouchi, T., 2015:
Sagittal gap balancing with the concept of a single radius femoral component in posterior cruciate sacrificing total knee arthroplasty with patient-specific instrumentation

Zemann, W.; Mossböck, R.; Kärcher, H.; Kozelj, V., 2007:
Sagittal growth of the facial skeleton of 6-year-old children with a complete unilateral cleft of lip, alveolus and palate treated with two different protocols

Sataa, S.; Ramzi, M.; Zouheir, F.; Said, B.Mohamed.; Mohamed, C.; Yassine, N.; Ali, H., 2009:
Sagittal incomplete hypospadiac anterior duplication of the urethra

Rey, J.; Fischer, M.S.; Böttcher, P., 2015:
Sagittal joint instability in the cranial cruciate ligament insufficient canine stifle. Caudal slippage of the femur and not cranial tibial subluxation

Yeow, C.H.; Lee, P.V.S.; Goh, J.C.H., 2010:
Sagittal knee joint kinematics and energetics in response to different landing heights and techniques

Chouteau, J.; Lerat, J.Luc.; Testa, R.; Moyen, B.; Banks, S.A.; Scott, B.A., 2008:
Sagittal laxity after posterior cruciate ligament-retaining mobile-bearing total knee arthroplasty

Woods, M.G., 2008:
Sagittal mandibular changes with overbite correction in subjects with different mandibular growth directions: late mixed-dentition treatment effects

Jena, A.Kumar.; Singh, S.Pal.; Utreja, A.Kumar., 2010:
Sagittal mandibular development effects on the dimensions of the awake pharyngeal airway passage

de Oliveira, Júlio.César.Silva.; Garcia, I.Rangel.; de Melo, W.Morais.; de Matos Barbosa, S.; Rabêlo, P.Maria.Santos.; Bastos, E.Guimarães., 2015 :
Sagittal mandibular osteotomy for removal of intraosseous lesion

Zemann, W.; Kärcher, H.; Drevenšek, M.; Koželj, V., 2012:
Sagittal maxillary growth in children with unilateral cleft of the lip, alveolus and palate at the age of 10 years: an intercentre comparison

Chen, Z-Qi.; Qian, Y-Fen.; Wang, G-Min.; Shen, G., 2010:
Sagittal maxillary growth in patients with unoperated isolated cleft palate

Chen, Z-Qi.; Wu, J.; Chen, R-Jing., 2012:
Sagittal maxillary growth pattern in unilateral cleft lip and palate patients with unrepaired cleft palate

Schlesinger, A.E.; Crowe, J.E., 2011:
Sagittal orientation of ingested coins in the esophagus in children

Pećina, M.; Ivković, A.; Hudetz, D.; Smoljanović, T.; Janković, S., 2010:
Sagittal osteotomy of the patella after Morscher

Le Huec, J.C.; Demezon, H.; Aunoble, S., 2015:
Sagittal parameters of global cervical balance using EOS imaging: normative values from a prospective cohort of asymptomatic volunteers

Mac-Thiong, J-Marc.; Roussouly, P.; Berthonnaud, E.; Guigui, P., 2011:
Sagittal parameters of global spinal balance: normative values from a prospective cohort of seven hundred nine Caucasian asymptomatic adults

Faundez, A.A.; Le Huec, J.Charles., 2014:
Sagittal plane analysis

Liu, T.; Hai, Y., 2014:
Sagittal plane analysis of selective posterior thoracic spinal fusion in adolescent idiopathic scoliosis: a comparison study of all pedicle screw and hybrid instrumentation

Li, W-Shi.; Li, G.; Chen, Z-Qiang.; Wood, K.B., 2011:
Sagittal plane analysis of the spine and pelvis in adult idiopathic scoliosis

Chandrasekaran, S.; Scarvell, J.M.; Buirski, G.; Woods, K.R.; Smith, P.N., 2012:
Sagittal plane articulation of the contralateral knee of subjects with posterior cruciate ligament deficiency: an observational study

Winter, D.A., 1987:
Sagittal plane balance and posture in human walking

Manson, T.T.; Khanuja, H.S.; Jacobs, M.A.; Hungerford, M.W., 2009:
Sagittal plane balancing in the total knee arthroplasty

Haris Phuah, A.; Schache, A.G.; Crossley, K.M.; Wrigley, T.V.; Creaby, M.W., 2010:
Sagittal plane bending moments acting on the lower leg during running

Brantingham, J.W.; Lee Gilbert, J.; Shaik, J.; Globe, G., 2006:
Sagittal plane blockage of the foot, ankle and hallux and foot alignment-prevalence and association with low back pain

Ali, N.; Robertson, D.Gordon.E.; Rouhi, G., 2014:
Sagittal plane body kinematics and kinetics during single-leg landing from increasing vertical heights and horizontal distances: implications for risk of non-contact ACL injury

Schwab, F.; Lafage, V.; Patel, A.; Farcy, J-Pierre., 2009:
Sagittal plane considerations and the pelvis in the adult patient

Kanayama, M., 2013:
Sagittal plane correction in pedicle subtraction osteotomy using the Xia 3 SUK Direct Vertebral Rotation System: technical note

McCarthy, J.J.; Davidson, R.S.; Ast, M.P.; Cavorsi, G.M.; Swick, J., 2012:
Sagittal plane deformity during femoral lengthening

Streubel, P.N.; Glasgow, D.; Wong, A.; Barei, D.P.; Ricci, W.M.; Gardner, M.J., 2011:
Sagittal plane deformity in bicondylar tibial plateau fractures

Joseph, S.A.; Moreno, A.P.; Brandoff, J.; Casden, A.C.; Kuflik, P.; Neuwirth, M.G., 2009:
Sagittal plane deformity in the adult patient

Roussouly, P.; Nnadi, C., 2011:
Sagittal plane deformity: an overview of interpretation and management

Narkbunnam, R.; Chareancholvanich, K.; Hanroongroj, T., 2015:
Sagittal plane evaluation of patellofemoral movement in patellofemoral pain patients with no evidence of maltracking

Eitzen, I.; Fernandes, L.; Nordsletten, L.; Risberg, M.Arna., 2013:
Sagittal plane gait characteristics in hip osteoarthritis patients with mild to moderate symptoms compared to healthy controls: a cross-sectional study

Hobbs, S.J.; Clayton, H.M., 2014:
Sagittal plane ground reaction forces, centre of pressure and centre of mass in trotting horses

Foucher, K.C.; Schlink, B.R.; Shakoor, N.; Wimmer, M.A., 2012:
Sagittal plane hip motion reversals during walking are associated with disease severity and poorer function in subjects with hip osteoarthritis

Straudi, S.; Manca, M.; Aiello, E.; Ferraresi, G.; Cavazza, S.; Basaglia, N., 2010:
Sagittal plane kinematic analysis of the six-minute walk test: a classification of hemiplegic gait

Rendos, N.K.; Harrison, B.C.; Dicharry, J.M.; Sauer, L.D.; Hart, J.M., 2014:
Sagittal plane kinematics during the transition run in triathletes

Tibesku, C.O.; Daniilidis, K.; Vieth, V.; Skwara, A.; Heindel, W.; Fuchs-Winkelmann, S., 2012:
Sagittal plane kinematics of fixed- and mobile-bearing total knee replacements

Gatt, A.; Chockalingam, N.; Falzon, O., 2014:
Sagittal plane kinematics of passive dorsiflexion of the foot in adolescent athletes

Zheng, L.; Jahn, J.; Vasavada, A.N., 2012:
Sagittal plane kinematics of the adult hyoid bone

Gatt, A.; Chockalingam, N.; Chevalier, T.Larose., 2012:
Sagittal plane kinematics of the foot during passive ankle dorsiflexion

Hart, J.M.; Ko, J-Wei.Kevin.; Konold, T.; Pietrosimone, B.; Pietrosimione, B., 2010:
Sagittal plane knee joint moments following anterior cruciate ligament injury and reconstruction: a systematic review

Na, K-Ho.; Harms, Jürgen.; Ha, K-Yong.; Choi, N-Yong., 2007:
Sagittal plane lumbar responses after anterior selective thoracic fusion for main thoracic adolescent idiopathic scoliosis

Sealey, R.J.; Myerson, M.S.; Molloy, A.; Gamba, C.; Jeng, C.; Kalesan, B., 2009:
Sagittal plane motion of the hindfoot following ankle arthrodesis: a prospective analysis

Rusaw, D.; Ramstrand, N., 2010:
Sagittal plane position of the functional joint centre of prosthetic foot/ankle mechanisms

Teng, H-Ling.; Powers, C.M., 2015:
Sagittal plane trunk posture influences patellofemoral joint stress during running

Park, M.Soo.; Mesfin, A.; Stoker, G.E.; Song, K-Sup.; Kennedy, C.; Riew, K.Daniel., 2014:
Sagittal range of motion after extensive cervical fusion

Schwab, F.J.; Patel, A.; Shaffrey, C.I.; Smith, J.S.; Farcy, J-Pierre.; Boachie-Adjei, O.; Hostin, R.A.; Hart, R.A.; Akbarnia, B.A.; Burton, D.C.; Bess, S.; Lafage, V., 2012:
Sagittal realignment failures following pedicle subtraction osteotomy surgery: are we doing enough?: Clinical article

Kimura, Y.; Ishibashi, Y.; Tsuda, E.; Fukuda, A.; Tsukada, H., 2009:
Sagittal realignment osteotomy for increased posterior tibial slope after opening-wedge high tibial osteotomy: a case report

Rousseau, M-Antoine.; Lazennec, J-Yves.; Tassin, J-Louis.; Fort, D., 2014:
Sagittal rebalancing of the pelvis and the thoracic spine after pedicle subtraction osteotomy at the lumbar level

Del Piñal, F.; García-Bernal, F.J.; Studer, A.; Regalado, J.; Ayala, H.; Cagigal, L., 2009:
Sagittal rotational malunions of the distal radius: the role of pure derotational osteotomy

Cho, D-Young.; Shin, M-Hoon.; Hur, J-Woo.; Ryu, K-Sik.; Park, C-Kun., 2013:
Sagittal sacropelvic morphology and balance in patients with sacroiliac joint pain following lumbar fusion surgery

Faldini, C.; Pagkrati, S.; Leonetti, D.; Miscione, M.Teresa.; Giannini, S., 2011:
Sagittal segmental alignment as predictor of adjacent-level degeneration after a cloward procedure

Madrazo Delgado, M.; Redondo Calvo, F.J.; Gil Trujillo, S.; Castillo, J.L.; Calvo García, M.; Bernal García, G., 2008:
Sagittal sinus thrombosis as a rare cause of postpartum headache: a case report

Wani, N.A.; Kosar, T.; Pala, N.A.; Qureshi, U.A., 2010:
Sagittal sinus thrombosis due to L-asparaginase

D'Angelo-Donovan, D.; Guarino, M.J., 2012:
Sagittal sinus thrombosis while on tamoxifen requiring craniectomy

Weber, J.; Vida, M.; Greiner, K., 2013:
Sagittal sinus thrombosis with malignant brain oedema: pathophysiology of cortical veins after decompressive craniectomy

Tripathi, M.; D'Souza, M.; Jain, J.; Kumari, R.; Guliani, S.; Pandey, S.K.; Sharma, R.; Mondal, A., 2011:
Sagittal sinus tumor thrombosis in a case of NHL demonstrated on F-18 FDG PET/CT

Tschechne, S.; Müller, B.; Dibbets, J., 2008:
Sagittal space relations in the maxilla during molar eruption

Endo, K.; Suzuki, H.; Tanaka, H.; Kang, Y.; Yamamoto, K., 2010:
Sagittal spinal alignment in patients with lumbar disc herniation

Winter, R.B.; Lonstein, J.E.; Denis, F., 2009:
Sagittal spinal alignment: the true measurement, norms, and description of correction for thoracic kyphosis

López-Miñarro, P.A.; Muyor, Jé.M.; Alacid, F., 2011:
Sagittal spinal and pelvic postures of highly-trained young canoeists

Videbaek, T.S.; Bünger, C.E.; Henriksen, M.; Neils, E.; Christensen, F.B., 2011:
Sagittal spinal balance after lumbar spinal fusion: the impact of anterior column support results from a randomized clinical trial with an eight- to thirteen-year radiographic follow-up

Muyor, Jé.M.; Sánchez-Sánchez, Eía.; Sanz-Rivas, D.; López-Miñarro, P.A., 2013:
Sagittal spinal morphology in highly trained adolescent tennis players

Klineberg, E.; Schwab, F.; Smith, J.S.; Gupta, M.C.; Lafage, V.; Bess, S., 2013:
Sagittal spinal pelvic alignment

Kuo, Y-Liang.; Tully, E.A.; Galea, M.P., 2009:
Sagittal spinal posture after Pilates-based exercise in healthy older adults

Lafage, V.; Smith, J.S.; Bess, S.; Schwab, F.J.; Ames, C.P.; Klineberg, E.; Arlet, V.; Hostin, R.; Burton, D.C.; Shaffrey, C.I., 2012:
Sagittal spino-pelvic alignment failures following three column thoracic osteotomy for adult spinal deformity

Le Huec, J.C.; Roussouly, P., 2012:
Sagittal spino-pelvic balance is a crucial analysis for normal and degenerative spine

Schuller, Sébastien.; Charles, Y.Philippe.; Steib, J-Paul., 2012:
Sagittal spinopelvic alignment and body mass index in patients with degenerative spondylolisthesis

Zhu, Z.; Sha, S.; Liu, Z.; Sun, X.; Jiang, L.; Yan, H.; Qian, B.; Qiu, Y., 2015:
Sagittal spinopelvic alignment in adolescent thoracic scoliosis secondary to Chiari I malformation: a comparison between the left and the right curves

Jiang, L.; Qiu, Y.; Xu, L.; Liu, Z.; Wang, Z.; Sha, S.; Zhu, Z., 2015:
Sagittal spinopelvic alignment in adolescents associated with Scheuermann's kyphosis: a comparison with normal population

Oh, J.Keun.; Smith, J.S.; Shaffrey, C.I.; Lafage, V.; Schwab, F.; Ames, C.P.; Matsumoto, M.; Baik, J.Sam.; Ha, Y., 2015:
Sagittal spinopelvic malalignment in Parkinson disease: prevalence and associations with disease severity

Karikari, I.O.; Mehta, A.I.; Solakoglu, C.; Bagley, C.A.; Ain, M.C.; Gottfried, O.N., 2012:
Sagittal spinopelvic parameters in children with achondroplasia: identification of 2 distinct groups

Kahnberg, K-Erik.; Kashani, H.; Owman-Moll, P., 2007:
Sagittal split advancement osteotomy: comparison of the tendency to relapse after two different methods of rigid fixation

Schendel, S.A., 2010:
Sagittal split genioplasty: a new technique

Greig, A.V.H.; Kapadia, H.; Grayson, B.H.; McCarthy, J.G., 2012:
Sagittal split osteotomy in a previously distracted mandible

Longo, B.; Nicolotti, M.; Ferri, G.; Belli, E.; Santanelli, F., 2014:
Sagittal split osteotomy of the fibula for modeling the new mandibular angle

Kim, J-Wook.; Lee, C-Hee.; Kwon, T-Geon., 2015:
Sagittal split osteotomy on the previously reconstructed mandible with fibula free flap

Dolphens, M.; Cagnie, B.; Coorevits, P.; Vanderstraeten, G.; Cardon, G.; Dʼhooge, R.; Danneels, L., 2013:
Sagittal standing posture and its association with spinal pain: a school-based epidemiological study of 1196 Flemish adolescents before age at peak height velocity

Araújo, Fábio.; Lucas, R.; Alegrete, N.; Azevedo, A.; Barros, H., 2015:
Sagittal standing posture, back pain, and quality of life among adults from the general population: a sex-specific association

McHenry, B.D.; Exten, E.L.; Long, J.; Law, B.; Marks, R.M.; Harris, G., 2015:
Sagittal subtalar and talocrural joint assessment with weight-bearing fluoroscopy during barefoot ambulation

Buchmann, E.J.; Libhaber, E., 2008:
Sagittal suture overlap in cephalopelvic disproportion: blinded and non-participant assessment

Masand, M., 2013:
Sagittal synostosis

Piatt, J.H., 2010:
Sagittal synostosis and ossified scalp hematoma: cause or consequence?

Currarino, G., 2007:
Sagittal synostosis in X-linked hypophosphatemic rickets and related diseases

Murray, D.J.; Kelleher, M.O.; McGillivary, A.; Allcutt, D.; Earley, M.J., 2007:
Sagittal synostosis: a review of 53 cases of sagittal suturectomy in one unit

Kohan, E.; Wexler, A.; Cahan, L.; Kawamoto, H.K.; Katchikian, H.; Bradley, J.P., 2009:
Sagittal synostotic twins: reverse pi procedure for scaphocephaly correction gives superior result compared to endoscopic repair followed by helmet therapy

Nouira, F.; Sarrai, N.; Ghorbel, S.; Khemakhem, R.; Chariag, W.; Jlidi, S.; Chaouachi, B., 2012:
Sagittal uretral duplication in boy

Ichiba, A.; Kido, H.; Tokuyama, F.; Makuya, K.; Oda, K., 2014:
Sagittal view of the tibial attachment of the anterior cruciate ligament on magnetic resonance imaging and the relationship between anterior cruciate ligament size and the physical characteristics of patients

Hanson, E.H.; Mishra, R.K.; Chang, D.S.; Perkins, T.G.; Bonifield, D.R.; Tandy, R.D.; Cartwright, P.E.; Peoples, R.R.; Orrison, W.W., 2010:
Sagittal whole-spine magnetic resonance imaging in 750 consecutive outpatients: accurate determination of the number of lumbar vertebral bodies

Larsen, H.J.; Sørensen, H.B.; Artmann, L.; Christensen, I.J.; Kjaer, I., 2010:
Sagittal, vertical and transversal dimensions of the maxillary complex in patients with ectopic maxillary canines

Blackburn, J.Troy.; Padua, D.A., 2009:
Sagittal-plane trunk position, landing forces, and quadriceps electromyographic activity

Tsai, H-Yun.; Lee, M-Hsuan.; Chen, H-Chi.; Chen, H-Chun.; Guh, J-Yuh., 2016:
Sagittally malrotated kidney: a case series of two patients

Arditty, H.J.; Leèfovre, H.C., 1981:
Sagnac effect in fiber gyroscopes

Huang, A.; Whitaker, N.; Avramopoulos, H.; French, P.; Houh, H.; Chuang, I., 1994:
Sagnac fiber logic gates and their possible applications: a system perspective

Refael, G.; Heo, J.; Bockrath, M., 2007:
Sagnac interference in carbon nanotube loops

Lee, C-Wei.; Wang, R.; Yeh, P.; Cheng, W-Hi., 2006:
Sagnac interferometer based flat-top birefringent interleaver

Shiokawa, N.; Mizuno, Y.; Tsuchiya, H.; Tokunaga, E., 2012:
Sagnac interferometer for photothermal deflection spectroscopy

Kråkenes, K.; Bløtekjaer, K., 1989:
Sagnac interferometer for underwater sound detection: noise properties

Jones, P.H.; Rashid, M.; Makita, M.; Maragò, O.M., 2009:
Sagnac interferometer method for synthesis of fractional polarization vortices

Bortolozzo, U.; Residori, S.; Rubin, J.L.; Huignard, J.P., 2011:
Sagnac interferometer with adaptive nonlinear detection

Garvey, D.W.; Li, Q.; Kuzyk, M.G.; Dirk, C.W.; Martinez, S., 1996:
Sagnac interferometric intensity-dependent refractive-index measurements of polymer optical fiber

Roither, S.; Verhoef, A.J.; Mücke, O.D.; Reider, G.A.; Pugžlys, A.; Baltuška, A., 2012:
Sagnac interferometric multipass loop amplifier

Kim, D-Hyun.; Kang, J., 2004:
Sagnac loop interferometer based on polarization maintaining photonic crystal fiber with reduced temperature sensitivity

Zhang, Y.; Yang, S.; Guan, H.; Lim, A.Eu-Jin.; Lo, G-Qiang.; Magill, P.; Baehr-Jones, T.; Hochberg, M., 2014:
Sagnac loop mirror and micro-ring based laser cavity for silicon-on-insulator

Hariharan, P., 1975:
Sagnac or Michelson-Sagnac interferometer?

Bogdanski, J.; Ahrens, J.; Bourennane, M., 2009:
Sagnac secret sharing over telecom fiber networks

Rønnekleiv, E., 1997:
Sagnac sensor for location of a disturbance

Tay, J.Wei.; Taylor, M.A.; Bowen, W.P., 2009:
Sagnac-interferometer-based characterization of spatial light modulators

Tselikov, A.; Blake, J., 2008:
Sagnac-interferometer-based fresnel flow probe

Ng, T.Tjuen.; Gosal, D.; Lamas-Linares, Aía.; Kurtsiefer, C., 2011:
Sagnac-loop phase shifter with polarization-independent operation

Fomitchov, P.A.; Kromine, A.K.; Krishnaswamy, S.; Achenbach, J.D., 2008:
Sagnac-type fiber-optic array sensor for detection of bulk ultrasonic waves

Linggang, S.; Phang, L.Y.; Wasoh, M.H.; Abd-Aziz, S., 2012:
Sago pith residue as an alternative cheap substrate for fermentable sugars production

Yang, X.; Barton, H.J.; Wan, Z.; Li, Q.; Ma, Z.; Li, M.; Zhang, D.; Wei, J., 2013:
Sago-type palms were an important plant food prior to rice in southern subtropical China

Klar, U.; Hoffmann, J.; Giurescu, M., 2008:
Sagopilone (ZK-EPO): from a natural product to a fully synthetic clinical development candidate

Hoffmann, J.; Fichtner, I.; Lemm, M.; Lienau, P.; Hess-Stumpp, H.; Rotgeri, A.; Hofmann, B.; Klar, U., 2008:
Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases

Strube, A.; Hoffmann, J.; Stepina, E.; Hauff, P.; Klar, U.; Käkönen, S-Maria., 2009:
Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption

Galmarini, C.M., 2010:
Sagopilone, a microtubule stabilizer for the potential treatment of cancer

Martínez-Ripoll, Mín., 2012:
Sagrario Martínez-Carrera (1925-2011)

Duplantie, Aée., 2010:
Saguenay-Lac-Saint-Jean, Genetic tests. A pilot project to screen for four recessive genes during pregnancy. Importance of support from the nurse

Toksen, E.; Boxshall, G.A.; Altinozek, S., 2012:
Sagum posteli Delamare-Deboutteville & Nunes-Ruivo, 1954 (Copepoda: Siphonostomatoida: Lernanthropidae) parasitic on Epinephelus aeneus (Geoffroy Saint-Hilaire) in Turkish waters, with a key to the species of Sagum Wilson, 1913

Saha, M.V.; Davis, R.E.; Hondula, D.M., 2014:
Saha et al. respond to "Mortality displacement after heat waves"

Reeves, H.M., 2009:
Sahagún's "Florentine codex," a little known Aztecan natural history of the Valley of Mexico

Yalta, K.; Sivri, N.; Yetkin, E., 2012:
Sahaja yoga: a unique adjunctive approach for the management of cardiac arrhythmias?

Nikita, E.; Mattingly, D.; Lahr, M.Mirazón., 2012:
Sahara: Barrier or corridor? Nonmetric cranial traits and biological affinities of North African late Holocene populations

Mallone, S.; Stafoggia, M.; Faustini, A.; Gobbi, G.Paolo.; Marconi, A.; Forastiere, F., 2012:
Saharan dust and associations between particulate matter and daily mortality in Rome, Italy

Matassoni, L.; Pratesi, G.; Centioli, D.; Cadoni, F.; Lucarelli, F.; Nava, S.; Malesani, P., 2011:
Saharan dust contribution to PM₁₀, PM₂.₅ and PM₁ in urban and suburban areas of Rome: a comparison between single-particle SEM-EDS analysis and whole-sample PIXE analysis

Gallisai, R.; Peters, F.; Volpe, G.; Basart, S.; Baldasano, Jé.Maria., 2015:
Saharan dust deposition may affect phytoplankton growth in the Mediterranean sea at ecological time scales

Dadvand, P.; Basagaña, X.; Figueras, F.; Amoly, E.; Tobias, A.; de Nazelle, A.; Querol, X.; Sunyer, J.; Nieuwenhuijsen, M.J., 2012:
Saharan dust episodes and pregnancy

Matassoni, L.; Pratesi, G.; Centioli, D.; Cadoni, F.; Malesani, P.; Caricchia, A.Maria.; di Bucchianico, A.Di.Menno., 2009:
Saharan dust episodes in Italy: influence on PM10 daily limit value (DLV) exceedances and the related synoptic

de Longueville, F.; Henry, S.; Ozer, P., 2009:
Saharan dust pollution: implications for the Sahel? [corrected

Flavell, G., 2012:
Saharan surgeon

Walsh, J., 1984:
Sahel Will Suffer Even if Rains Come: With potential population explosion, no Green Revolution, drought is only part of the problem confronting the region

Ceesay, S.J.; Bojang, K.A.; Nwakanma, D.; Conway, D.J.; Koita, O.A.; Doumbia, S.O.; Ndiaye, D.; Coulibaly, T.F.; Diakité, M.; Traoré, S.F.; Coulibaly, M.; Ndiaye, J-Louis.; Sarr, O.; Gaye, O.; Konaté, L.; Sy, N.; Faye, B.; Faye, O.; Sogoba, N.; Jawara, M.; Dao, A.; Poudiougou, B.; Diawara, S.; Okebe, J.; Sangaré, L.; Abubakar, I.; Sissako, A.; Diarra, A.; Kéita, M.; Kandeh, B.; Long, C.A.; Fairhurst, R.M.; Duraisingh, M.; Perry, R.; Muskavitch, M.A.T.; Valim, C.; Volkman, S.K.; Wirth, D.F.;, 2012:
Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes

Wade, N., 1974:
Sahelian drought: no victory for Western aid

Eckerström, M.; Skoogh, J.; Rolstad, S.; Göthlin, M.; Steineck, G.; Johansson, B.; Wallin, A., 2013:
Sahlgrenska Academy Self-reported Cognitive Impairment Questionnaire (SASCI-Q)--a research tool discriminating between subjectively cognitively impaired patients and healthy controls

Biörserud, C.; Nielsen, C.; Staalesen, T.; Elander, A.; Olbers, T.; Olsén, M.Fagevik., 2013:
Sahlgrenska Excess Skin Questionnaire (SESQ): a reliable questionnaire to assess the experience of excessive skin after weight loss

Boycott, A.E., 1912 :
Sahli's Haemoglobinometer

Boycott, A.E., 1912:
Sahli's Hæmoglobinometer

Sahraoui, F.; Robert, P.; Goldstein, M.L.; Khotyaintsev, Y.V., 2013:
Sahraoui et al. reply

Komiya, K.; Ishii, H.; Ohama, M.; Uchida, M.; Tsubone, T.; Iwashita, T.; Miyajima, H.; Okabe, E.; Matsumoto, T.; Matsumoto, B.; Kadota, J-ichi., 2013:
Sai-rei-to-induced lung injury: a case report and brief review of the literature

Maurer, B.T., 2013:
Said and done: when the present is all we have left

Ayres, C.G., 2009:
Said another way. Nurses' role in cancer control

Gugerty, L., 2008:
Said another way. Nursing care: a lost art

West, E., 2009:
Said another way. The real cost of higher education

Goodman, W.M.; Lamers, A., 2011:
Said another way: asking the right questions regarding the effectiveness of simulations

Tzeng, H-Ming.; Yin, C-Yi., 2007:
Said another way: seeing the nursing profession from a different perspective: nurstry? Why not!

Lavin, R.P.; Dreyfus, M.; Slepski, L.; Kasper, C.E., 2007:
Said another way: subject matter experts: facts or fiction?

Kilcullen, N.M., 2007:
Said another way: the impact of mentorship on clinical learning

Mizoguchi, K.; Ikeda, R.; Shoji, H.; Tanaka, Y.; Jin, X-Long.; Kase, Y.; Takeda, S.; Maruyama, W.; Tabira, T., 2008:
Saikokaryukotsuboreito, a herbal medicine, prevents chronic stress-induced anxiety in rats: comparison with diazepam

Ohta, Y.; Kongo-Nishimura, M.; Hayashi, T.; Kitagawa, A.; Matsura, T.; Yamada, K., 2008:
Saikokeishito Extract Exerts a Therapeutic Effect on alpha-Naphthylisothiocyanate-Induced Liver Injury in Rats through Attenuation of Enhanced Neutrophil Infiltration and Oxidative Stress in the Liver Tissue

Zhu, J.; Luo, C.; Wang, P.; He, Q.; Zhou, J.; Peng, H., 2013:
Saikosaponin A mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells

Wang, X.; Wang, Q.; Burczynski, F.J.; Kong, W.; Gong, Y., 2014:
Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activation

Lee, T.Ho.; Chang, J.; Kim, B.Mo., 2014:
Saikosaponin C inhibits lipopolysaccharide-induced apoptosis by suppressing caspase-3 activation and subsequent degradation of focal adhesion kinase in human umbilical vein endothelial cells

Li, Z-Yang.; Jiang, Y-Mao.; Liu, Y-Min.; Guo, Z.; Shen, S-Nan.; Liu, X-Min.; Pan, R-Le., 2015:
Saikosaponin D acts against corticosterone-induced apoptosis via regulation of mitochondrial GR translocation and a GR-dependent pathway

Chen, L.; Zhang, F.; Kong, D.; Zhu, X.; Chen, W.; Wang, A.; Zheng, S., 2013:
Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity

Chen, M.Feng.; Huang, C.Cheng.; Liu, P.Shan.; Chen, C.Han.; Shiu, L.Yen., 2014:
Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells

Sun, Y.; Cai, T-Tian.; Zhou, X-Bin.; Xu, Q., 2009:
Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis

Yu, Y-Hong.; Xie, W.; Bao, Y.; Li, H-Ming.; Hu, S-Jue.; Xing, J-Ling., 2013:
Saikosaponin a mediates the anticonvulsant properties in the HNC models of AE and SE by inhibiting NMDA receptor current and persistent sodium current

Liu, A.; Tanaka, N.; Sun, L.; Guo, B.; Kim, J-Hwan.; Krausz, K.W.; Fang, Z.; Jiang, C.; Yang, J.; Gonzalez, F.J., 2017:
Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signaling

Zhang, B-Zhen.; Guo, X-Tong.; Chen, J-Wei.; Zhao, Y.; Cong, X.; Jiang, Z-Ling.; Cao, R-Feng.; Cui, K.; Gao, S-Song.; Tian, W-Ru., 2015:
Saikosaponin-D attenuates heat stress-induced oxidative damage in LLC-PK1 cells by increasing the expression of anti-oxidant enzymes and HSP72

Wang, B-Feng.; Wang, X-Jing.; Kang, H-Feng.; Bai, M-Hua.; Guan, H-Tao.; Wang, Z-Wei.; Zan, Y.; Song, L-Qin.; Min, W-Li.; Lin, S.; Cheng, Y-An., 2016:
Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1α

Wong, V.Kam.Wai.; Zhang, M.Miao.; Zhou, H.; Lam, K.Yin.Ching.; Chan, P.Ling.; Law, C.Ka.Man.; Yue, P.Ying.Kit.; Liu, L., 2013:
Saikosaponin-d Enhances the Anticancer Potency of TNF-α via Overcoming Its Undesirable Response of Activating NF-Kappa B Signalling in Cancer Cells

Ying, Z-Lin.; Li, X-Jie.; Dang, H.; Wang, F.; Xu, X-Yan., 2014:
Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells

Wang, B-Feng.; Dai, Z-Jun.; Wang, X-Jing.; Bai, M-Hua.; Lin, S.; Ma, H-Bing.; Wang, Y-Li.; Song, L-Qin.; Ma, X-Long.; Zan, Y.; Min, W-Li.; Cheng, Y-An., 2014 :
Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle

Liu, R-Y.; Li, J-P., 2016:
Saikosaponin-d inhibits proliferation of human undifferentiated thyroid carcinoma cells through induction of apoptosis and cell cycle arrest

Hao, Y.; Piao, X.; Piao, X., 2012:
Saikosaponin-d inhibits β-conglycinin induced activation of rat basophilic leukemia-2H3 cells

Wu, G-C.; Wu, H.; Fan, L-Y.; Pan, H-F., 2011:
Saikosaponins: a potential treatment option for systemic lupus erythematosus

Yao, M.; Yang, J.; Cao, L.; Zhang, L.; Qu, S.; Gao, H., 2015:
Saikosaponin‑d inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase

He, S.; Lu, G.; Hou, H.; Zhao, Z.; Zhu, Z.; Lu, X.; Chen, J.; Wang, Z., 2015:
Saikosaponin‑d suppresses the expression of cyclooxygenase‑2 through the phospho‑signal transducer and activator of transcription 3/hypoxia‑inducible factor‑1α pathway in hepatocellular carcinoma cells

Shrubb, R., 2011:
Sail away

Nicol, P.; Young, M., 2007:
Sail training: an innovative approach to graduate nurse preceptor development